JPH0534024B2 - - Google Patents
Info
- Publication number
- JPH0534024B2 JPH0534024B2 JP1278684A JP27868489A JPH0534024B2 JP H0534024 B2 JPH0534024 B2 JP H0534024B2 JP 1278684 A JP1278684 A JP 1278684A JP 27868489 A JP27868489 A JP 27868489A JP H0534024 B2 JPH0534024 B2 JP H0534024B2
- Authority
- JP
- Japan
- Prior art keywords
- autoantibodies
- immune complexes
- adsorption
- adsorbent
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003463 adsorbent Substances 0.000 claims description 38
- 230000002209 hydrophobic effect Effects 0.000 claims description 36
- 150000001413 amino acids Chemical class 0.000 claims description 26
- 210000004369 blood Anatomy 0.000 claims description 17
- 239000008280 blood Substances 0.000 claims description 17
- 239000002504 physiological saline solution Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 description 34
- 229940024606 amino acid Drugs 0.000 description 24
- 150000001875 compounds Chemical class 0.000 description 19
- 239000002245 particle Substances 0.000 description 19
- 102000006395 Globulins Human genes 0.000 description 18
- 108010044091 Globulins Proteins 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- 239000011148 porous material Substances 0.000 description 15
- 102000009027 Albumins Human genes 0.000 description 13
- 108010088751 Albumins Proteins 0.000 description 13
- 210000001124 body fluid Anatomy 0.000 description 13
- 239000010839 body fluid Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 11
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 10
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 108060003951 Immunoglobulin Proteins 0.000 description 8
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 8
- 229920002684 Sepharose Polymers 0.000 description 8
- 239000000969 carrier Substances 0.000 description 8
- 102000018358 immunoglobulin Human genes 0.000 description 8
- 229960005190 phenylalanine Drugs 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 238000012092 latex agglutination test Methods 0.000 description 7
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 7
- -1 acrylic ester Chemical class 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- 102000015636 Oligopeptides Human genes 0.000 description 4
- 108010038807 Oligopeptides Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000035931 haemagglutination Effects 0.000 description 4
- 150000002433 hydrophilic molecules Chemical class 0.000 description 4
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000003172 anti-dna Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 239000012052 hydrophilic carrier Substances 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- KCUNTYMNJVXYKZ-JTQLQIEISA-N methyl (2s)-2-amino-3-(1h-indol-3-yl)propanoate Chemical compound C1=CC=C2C(C[C@H](N)C(=O)OC)=CNC2=C1 KCUNTYMNJVXYKZ-JTQLQIEISA-N 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108010009685 Cholinergic Receptors Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- 102000034337 acetylcholine receptors Human genes 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 150000001449 anionic compounds Chemical class 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 239000012051 hydrophobic carrier Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- YXMMTUJDQTVJEN-WDSKDSINSA-N methyl (2s,3s)-2-amino-3-methylpentanoate Chemical compound CC[C@H](C)[C@H](N)C(=O)OC YXMMTUJDQTVJEN-WDSKDSINSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 206010028417 myasthenia gravis Diseases 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- GDJWFFZFDYLDNY-UHFFFAOYSA-N C(C(=C)C)(=O)OCCO.C(CO)O Chemical compound C(C(=C)C)(=O)OCCO.C(CO)O GDJWFFZFDYLDNY-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000000781 anti-lymphocytic effect Effects 0.000 description 1
- 230000003598 anti-microsomal effect Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003210 demyelinating effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960001269 glycine hydrochloride Drugs 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 229940099472 immunoglobulin a Drugs 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
Description
æ¬çºæã¯ãçäœå
ç«æ©èœã«èµ·å ããåçš®çŸæ£ãš
å¯æ¥ãªé¢ä¿ããã€ãšèããããŠããèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœãç¹ç°çã«åžçé€å»ããã
è¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ã«é¢ããã åšç¥ã®åŠããè¡æ¶²äžã«çºçŸããèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœã¯ãçãå ç«å¢æ®æ§çå
矀ãæ ¢æ§é¢ç¯ãªãŠãããå šèº«æ§ãšãªããããŒãã¹
çã®èªå·±å ç«çŸæ£ããããã¯ã¢ã¬ã«ã®ãŒãèåšç§»
æ€æã®æ絶åå¿çã®çäœå ç«æ©èœã«é¢ä¿ããçŸæ£
ããã³çŸè±¡ã®åå ãããã¯é²è¡ãšå¯æ¥ãªé¢ä¿ãã
ã€ãŠãããšèããããŠããã ããã§ãè¡æ¶²ãè¡æŒ¿çã®äœæ¶²æåãããäžèšèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœãç¹ç°çã«åžç
é€å»ããããšã«ãã€ãŠãäžèšã®åŠãçŸæ£ã®é²è¡ã
é²æ¢ããçç¶ã軜æžããããããã«ã¯æ²»çãæ©ã
ãããšãæåŸ ãããŠããã åŸæ¥ããã®ãããªç®çã«äŸãåŸãåžçæãšããŠ
ã¯ããããã€ã³ïŒ¡ãäžæº¶æ§æ äœã«åºå®ãããåžç
æãã¢ã¯ãªã«é žãšã¹ãã«ç³»å€åæ§æš¹èïŒäŸãã°
XADâïŒãããŒã ã¢ã³ãããŒã¹ç€Ÿè£œïŒãããã¯
ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹çã®éœã€ãªã³äº€æäœ
ãææ¡ãããŠããã ããããªããããããã€ã³ïŒ¡ãäžæº¶æ§æ äœã«åº
å®ãããåžçæã¯ãèªå·±æäœããã³ïŒãŸãã¯å ç«
è€åäœã«å¯Ÿãç¹ç°çåžçæ©èœãæãããã®ã®ãé»
è²ãããŠçèç±æ¥ã®çç掻æ§ã¿ã³ãã¯è³ªã§ããã
ããåæ確ä¿ãå°é£ã§è£œåã³ã¹ããããããšãã
äžå©ç¹ãããããŸãã掻æ§ãäžå®å®ãªãããåºå®
åæã®åãæ±ããåºå®ååŸã®ä¿åçã«ãã倱掻ã
èµ·ããæãæ¬ ç¹ããããããã«ãäœæ¶²ã«æ¥è§Šãã
ããŠäœ¿çšããéã«ããããã€ã³ïŒ¡æº¶åºã«ããåŒå®³
ãçããå±éºããããå ããŠã倱掻ãæãã€ã€æ»
èããããšãå°é£ã§ãããšããé£ç¹ããã€ãã ãŸããã¢ã¯ãªã«é žãšã¹ãã«ç³»å€åæ§æš¹èããã³
ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã¯ãåžçèœãå°ã
ãããã®äžãåžçç¹ç°æ§ãäœããšããæ¬ ç¹ãã
ããããã«äœæ¶²äžã®ã¢ã«ããã³ããåžçããã®
ã§ã浞éå§ã®ç°åžžãããããå®å šãªæ²»çåšãšããŠ
å©çšããããšã¯äžå¯èœã§ãã€ãã æ¬çºæã®ç®çã¯ãäžèšã®åŠãåŸæ¥æè¡ã«åºã¥ã
èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®åžçæã®å
é¡ç¹ã«éã¿ãäžè¬çã«æ®åå¯èœã§ãããèªå·±æäœ
ããã³ïŒãŸãã¯å ç«è€åäœãé«æŽ»æ§ãã€ç¹ç°çã«
åžçããå®å®ãªæŽ»æ§ãä¿æããå®å šæ§ããããæ»
èæäœãç°¡æã«è¡ãããšãã§ããäœæ¶²æµåããã
ã¯åççšã«é©ããåžçæãå©çšããŠãèªå·±æäœã
ãã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»ãããè¡
液ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ãæäŸãããšããã
ã®ã§ããã æ¬çºæè ãã¯ãäžèšç®çã«æ²¿ã€ãŠéæç 究ãã
çµæãåçš®ã®ååç©ãäžæº¶æ§æ äœã«çµåããèªå·±
æäœããã³å ç«è€åäœã«å¯Ÿããçµå掻æ§ãè©äŸ¡ã
ããšãããå®ã«é©ãã¹ãããšã«ã¯ãäžæº¶æ§æ äœã
çµåããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœããã¢
ã«ããã³ãã»ãšãã©åžçããã極ããŠé«æŽ»æ§ãã€
ç¹ç°çã«èªå·±æäœãå ç«è€åäœãåžçããããšã
èŠåºããæ¬çºæãå®æããã«è³ã€ãã ããªãã¡ãæ¬çºæã¯ã25âã«ããã察ççé£å¡©
氎溶解床ã100ïœmolïŒdl以äžã§ããçæ°Žæ§ã¢ã
ãé žãŸãã¯ãã®èªå°äœããã³ïŒãŸãã¯è©²çæ°Žæ§ã¢
ããé žãŸãã¯ãã®èªå°äœãå«ããªãªãŽããŒãæ°Žäž
溶æ§æ äœïŒmlããã0.1ã30mgçµåãããŠãªãåž
çæã«ãèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãå ±
åããè¡æ¶²ãŸãã¯è¡æŒ¿ãæµãããšãç¹åŸŽãšããèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»
ãããè¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ã«ä¿ãã æ¬çºæã§å¯Ÿè±¡ãšããåžçç©è³ªã¯ãèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœã§ãããããã詳现ã«èª¬æ
ãããšããªãŠããå åãææ žæäœãæDNAæäœã
æãªã³ãçæäœãæèµ€è¡çæäœãæè¡å°æ¿æäœã
ã¢ã»ãã«ã³ãªã³ã¬ã»ãã¿ãŒæäœãè¡æž è±é«æäœã
æãµã€ãã°ãããªã³æäœãæãã€ã¯ããŸãŒã æ
äœãæå€§è žæäœçã®èªå·±æäœãèªå·±æäœã®éå ç
æç©ãååŠä¿®é£Ÿçæç©çã®ã€ã ãã°ãããªã³èªå°
äœãèªå·±æäœéãŸãã¯èªå·±æäœãšä»ã®ç©è³ªãç¹ã«
æåããã³æåæ§ç©è³ªãšã®è€åäœçã§ããããã
ãã®äžã§ãç¹ã«æ¬çºæã®å¯Ÿè±¡ãšããåžçç©è³ªãšã
ãŠå¥œãŸãããã®ã¯ãèªå·±å ç«çŸæ£ã®åå ããã³é²
è¡ãšæ·±ãé¢ããããã€èªå·±æäœããã³å ç«è€åäœ
ã§ããã æ¬çºæã«çšããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°
äœãšã¯ã察ççé£å¡©æ°Žæº¶è§£åºŠ100ããªã¢ã«ïŒdl以
äžïŒ25âïŒããã奜ãŸããã¯30ããªã¢ã«ïŒdl以äž
ã®ååç©ãããã察ççé£å¡©æ°Žæº¶è§£åºŠã100ããª
ã¢ã«ïŒdlãã倧ããååç©ã¯ã芪氎æ§ãé«ããªã
ãããèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœã«å¯Ÿã
ã芪ååãäœäžããçµæãåžçèœã極端ã«äœäžã
ãããŸãããã芪氎çãªã¢ã«ããã³ã«å¯Ÿãã芪å
åãçããŠãã¢ã«ããã³ããéç¹ç°çã«åžçãã
ããã«ãªã奜ãŸãããªãã çæ°Žæ§ã¢ããé žããã³ãã®èªå°äœãšã¯ã
Tanford.NozakiïŒJ.Am.Chem.Soc.ã184 4240
ïŒ1962ïŒãJ.Biol.Chem.246 2211ïŒ1971ïŒïŒãã¿ã³ã
ãªãŒãããã¶ãïŒãžã€ãŒãã«ã»ãªãã»ã¢ã¡ãªã«
ã³ã»ã±ãã«ã«ã»ãœãµãšãã€ã184ã4240ïŒ1962ïŒã
ãžã€ãŒãã«ã»ãªãã»ãã€ãªããžã«ã«ã»ã±ãã¹ããª
ã€246ã2211ïŒ1971ïŒãã«ããå®çŸ©ãããçæ°Žæ§å°º
床ã§ã¿ãŠã1500calïŒmol以äžã®ã¢ããé žããã³
ãã®èªå°äœã§ã察ççé£å¡©æ°Žæº¶è§£åºŠ100ããªã¢
ã«ïŒdl以äžã®ååç©ãæå³ãããäŸãã°ããªãž
ã³ãããªã³ããã€ã·ã³ãããã·ã³ãããšãã«ã¢ã©
ãã³ãã€ãœãã€ã·ã³ãããªãããã¢ã³ããã³ãã®
èªå°äœçã§ããããããã®çæ°Žæ§ã¢ããé žããã³
ãã®èªå°äœã®äžã§ã¯ãããªãããã¢ã³ããã³ãã®
èªå°äœãç¹ã«è¯å¥œãªçµæãäžããããŸããã¢ãã
é žã¯ïœãïœã®ç«äœé 座ãç¹ã«éå®ããããšãªã䜿
çšããããšãã§ããã çæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœã®ãã¡ãäžæº¶
æ§æ äœã«çµåããç¶æ ã§é解é£æ§ãäž¡ã€ãªã³æ§ã
ã«ããªã³æ§ã®ååç©ããèªå·±æäœããã³ïŒãŸãã¯
å ç«è€åäœãããéžæçã«åžçããã®ã§ãã¢ããª
ã³æ§ã®ååç©ããã¯å¥œãŸãããã¢ããªã³æ§ã®åå
ç©ã¯ãã¢ã«ããã³ååãèªå·±æäœããã³å ç«è€å
äœããé»æ°çã«é°æ§ã§ããããšããåœç¶äºæ³ãã
ãçµæã«åããŠãã¢ã«ããã³ã«èŠªåæ§ã§ãããèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®åžçéãäœäž
ãããäŸãã°ãããšãã«ã¢ã©ãã³ã¡ãã«ãšã¹ã
ã«ãããšãã«ã¢ã©ãã³ãããã·ã³ã¯ããã®çæ°Žæ§
ã«å€§ããªçžéããªããããã®ã¢ããåºã§äžæº¶æ§æ
äœã«å ±æçµåããèªå·±æäœåžçèœãè©äŸ¡ããæã
ããšãã«ã¢ã©ãã³ã¡ãã«ãšã¹ãã«ïŒããšãã«ã¢ã©
ãã³ããã·ã³ã®åºåã«ãªããããšãã«ã¢ã©ã
ã³ãããã·ã³ã¯ãåžçèœãäœäžããããšã«ãã®å®
äŸãã¿ãããšãã§ããããŸããéè³éŠæååç©ã
åæ§ã®çµæã瀺ãããç¹ã«ã¢ããªã³æ§åºãšããŠã
ã¹ã«ããªã³é žåºãæãããã芪氎æ§ããååç©
ã¯ãèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœããã¢ã«
ããã³ã«èŠªåçã§ãããã¢ã«ããã³åžçæãšããŠ
äœçšãããããã¯ååç©ã®é»è·ãšã¢ã«ããã³ãå
åå ã®ãã¯ããªç°å¢ã®é»è·ãšã®çžäºäœçšã«ããã
ã®ãšæšå®ãããã 以äžã®å®éšçµæããã¿ãŠãæ¬çºæã®äœçšã¡ã«ã
ãºã ã¯ãäžæº¶æ§æ äœã«çµåããçæ°Žæ§ååç©ãšèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®çæ°Žæ§çžäºäœ
çšåïŒVan der WaalsåïŒã«åºã¥ããã®ãšèã
ãããããŸããé éåãšããŠã®é»è·éçžäºäœçšå
ïŒã¯ãŒãã³åïŒãäºæ¬¡çã«äœçšããŠãããã®ãšæš
å®ãããã æ¬çºæã®çæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœãå«
ããªãªãŽããŒã¯ãååé1000以äžã®ãªãªãŽããŒã§
ãããããã«ãããããã€ã³ïŒ¡ïŒååé42000ïŒã®
ãããªå€©ç¶é«ååã«æ¯èŒããŠåºå®åæã®åãæ±
ããåºå®ååŸã®ä¿åã容æã«è¡ãããã®ã§ããã
ãŸããåœè©²ç©è³ªãäžæº¶æ§æ äœãã溶åºããå Žåã«
ããååéïŒäžä»¥äžã®ãªãªãŽããŒã¯ãçäœã«å¯Ÿã
ãæåæ§ãç¡èŠã§ããã»ã©å°ããå®å šã§ãããæ»
èæäœã容æã«è¡ãããã®ã§ããã該ãªãªãŽããŒ
ã¯ãçæ°Žæ§ååç©ã¢ãããŒåç¬ãŸãã¯ä»ã®ååç©
ãšã®å ±éåã«ããåŸããããçæ°Žæ§ã¢ããé žãŸã
ã¯ãã®èªå°äœã¢ãããŒãšããŠã¯ãäŸãã°ãããªã
ããã¢ã³çãçšããããšãã§ããã æ¬çºæã§çšããããäžæº¶æ§æ äœã¯ã芪氎æ§æ
äœãçæ°Žæ§æ äœãããã䜿çšã§ããããçæ°Žæ§æ
äœãçšããå Žåã«ã¯ãæã«æ äœãžã®ã¢ã«ããã³ã®
éç¹ç°çåžçãçããããã芪氎æ§æ äœã®æ¹ã奜
ãŸããçµæãäžããã äžæº¶æ§æ äœã®åœ¢ç¶ã¯ãç²åç¶ãç¹ç¶ç¶ãäžç©ºç³ž
ç¶ãèç¶çãããã®å ¬ç¥ã®åœ¢ç¶ãçšãããããç
æ°Žæ§ååç©ã®ä¿æéãåžçæãšããŠã®åãæ±ãæ§
ããã¿ãŠãç²åç¶ãç¹ç¶ç¶ã®ãã®ã奜ãŸããã ç²åç¶æ äœãšããŠã¯ãå¹³åç²åŸ150ÎŒãªãã
2500ÎŒã®ç¯å²ã«ããããšã奜ãŸãããå¹³åç²åŸã¯
JISââ8801ã«èŠå®ããããã«ã€ãçšããŠæµæ°Ž
äžã§åçŽããåŸãåçŽã®äžéç²åŸãšäžéç²åŸã®äž
éå€ãåçŽã®ç²åŸãšãããã®ééå¹³åãšããŠå¹³å
ç²åŸãç®åºããããŸããç²å圢ç¶ã¯ç圢ã奜ãŸã
ãããç¹ã«éå®ããããã®ã§ã¯ãªããå¹³åç²åŸã
2500Ό以äžã§ã¯ãèªå·±æäœããã³ïŒãŸãã¯å ç«è€
åäœã®åžçéåã³åžçé床ãäœäžãããã150ÎŒ
以äžã§ã¯ãååºç³»ã®æŽ»æ§åãè¡çç²çããããã
ããã䜿ãããç²åç¶æ äœãšããŠã¯ãã¢ã¬ããŒã¹
ç³»ãããã¹ãã©ã³ç³»ãã»ã«ããŒã¹ç³»ãããªã¢ã¯ãª
ã«ã¢ããç³»ãã¬ã©ã¹ç³»ã掻æ§çç³»ã®æ äœã§ãã
ããã²ã«æ§é ãæãã芪氎æ§æ äœãè¯å¥œãªçµæã
äžããããŸããéåžžåºå®åé µçŽ ãã¢ãã€ããã€ã¯
ãããã°ã©ãã€ã«çšããããå ¬ç¥ã®æ äœã¯ãç¹å¥
ãªéå®ãªã䜿çšããããšãã§ããã ç²åç¶æ äœãšããŠã¯ãå€åæ§ç²åãç¹ã«å€åæ§
éåäœãçšããããšãã§ãããæ¬çºæã§çšããã
ãå€åæ§éåäœç²åã¯ããã®è¡šé¢ã«çæ°Žæ§ååç©
ãåºå®åããããã®ã§ãããå¹³ååç³»300â«ãªã
ã9000â«ããã奜ãŸããã¯1000â«ãªãã6000â«ã®
ç¯å²ã«ãããã®ã§ãããéåäœçµæã¯ãããªã¢ã
ãç³»ãããªãšã¹ãã«ç³»ãããªãŠã¬ã¿ã³ç³»ãããã«
ååç©ã®éåäœçãå€åæ§æ§é ããšãããå ¬ç¥ã®
éåäœãçšããããšãã§ããããç¹ã«èŠªæ°Žæ§ã¢ã
ããŒã«ãã芪氎åããããã«ååç©ç³»å€åæ§éå
äœç²åã奜ãŸããçµæãäžããã 該å€åæ§æ§é ã¯ãå¹³åç²åŸ300â«ãªãã9000â«
ç¯å²ã«ããã®ã奜ãŸããããå¹³åååŸãå°ããã
ãå Žåã«ã¯ãåžçãããèªå·±æäœããã³ïŒãŸãã¯
å ç«è€åäœã®éãå°ãªãã倧ããããå Žåã«ã¯ã
éåäœç²åã®åŒ·åºŠãäœäžãããã€è¡šé¢ç©ãæžå°ã
ãããå®çšçã§ã¯ãªãã å¹³åååŸã®æž¬å®ã¯æ°Žéå§å ¥åŒããã·ã¡ãŒã¿ãŒã«
ãã€ãããã®æ¹æ³ã¯ãå€åæ§ç©è³ªã«æ°Žéãå§å ¥ã
ãŠãããæµžå ¥ããæ°Žééããæ°åéããå§å ¥ã«èŠ
ããå§åããååŸãæ±ããæ¹æ³ã§ããã40â«ä»¥äž
ã®åã枬å®ããããšãã§ãããæ¬çºæã®åãšã¯ã
ååŸã40â«ä»¥äžã®è¡šé¢ããã®é£éåãšå®çŸ©ããã
å¹³åååŸã¯ãååŸãïœãããã·ã¡ãŒã¿ãŒã§æž¬å®ã
ã环ç©æ°åéããšãããšããdVïŒïœ log ïœ
ã®å€ãæ倧ãšãªããšãã®ïœã®å€ãšããã ç¹ç¶ç¶æ äœãçšããå Žåã«ã¯ããã®ç¹ç¶åœ¢ã
0.02ãããŒã«ãªãã10ãããŒã«ããã奜ãŸããã¯
0.1ãããŒã«ãªããïŒãããŒã«ã®ç¯å²ã«ãããã®
ãè¯ããç¹ç¶åŸã倧ããããå Žåã«ã¯ãèªå·±æäœ
ããã³ïŒãŸãã¯å ç«è€åäœã®åžçéããã³åžçé
床ãäœäžããããå°ããããå Žåã«ã¯ãååºç³»ã®
掻æ§åãè¡çç²çãç®ã¥ãŸãããããããããçš
ãããç¹ç¶ç¶æ äœãšããŠã¯ãåçã»ã«ããŒã¹ç³»ç¹
ç¶ããã€ãã³ãã¢ã¯ãªã«ãããªãšãã«çå ¬ç¥ã®ç¹
ç¶ãäžè¬ã«çšããããšãã§ããã çæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœãäžæº¶æ§æ äœ
ã®è¡šé¢ã«åºå®ããæ¹æ³ã¯ãå ±æçµåãã€ãªã³çµ
åãç©çåžçãå åãããã¯éåäœè¡šé¢ãžã®æ²æŸ±
äžæº¶åçããããå ¬ç¥ã®æ¹æ³ãçšããããšãã§ã
ãããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœã®æº¶åºæ§
ããèãããšãå ±æçµåã«ãããåºå®ãäžæº¶åã
ãŠçšããããšã奜ãŸããããã®ããéåžžåºå®åé µ
çŽ ãã¢ãã€ããã€ã¯ãããã°ã©ãã€ã§çšãããã
å ¬ç¥ã®äžæº¶æ§æ äœã®æŽ»æ§åæ¹æ³ããã³çæ°Žæ§åå
ç©ãšã®çµåæ¹æ³ãçšããããšãã§ããããŸããå¿
èŠã«å€§ããŠäžæº¶æ§æ äœãšçæ°Žæ§ã¢ããé žãŸãã¯ã
ã®èªå°äœã®éã«ä»»æã®é·ãã®ååïŒã¹ããŒãµãŒïŒ
ãå°å ¥ããŠäœ¿çšããããšãã§ãããäŸãã°ãã¢ã¬
ããŒã¹ã®ããããã·ã«åºãšãããµã¡ãã¬ã³ãžã€ãœ
ã·ã¢ããŒãã®çåŽã®ã€ãœã·ã¢ããŒãåºãåå¿ãçµ
åãããæ®ã€ãã€ãœã·ã¢ããŒãåºãšçæ°Žæ§ã¢ãã
é žãŸãã¯ãã®èªå°äœã®ã¢ããåºãããããã·ã«
åºãã¹ã«ããããªã«åºãã«ã«ããã·ã«åºçãå
å¿ãçµåãããããšãå®æœããããšãã§ãããã¹
ããŒãµãŒé·ããšããŠã¯ãã¹ããŒãµãŒã®ãªããã®ã
ãããã®äžã«å«ãŸããååæ°ã§20ãŸã§ãç¹ã«å¥œãŸ
ããçµæãäžããã æ¬çºæã§äžæº¶æ§æ äœã«çµåããŠããçæ°Žæ§ã¢ã
ãé žãŸãã¯ãã®èªå°äœã®éã¯ãäžæº¶æ§æ äœïŒmlåœ
ãã0.1mgãªãã30mgã®ç¯å²ã§ããããã奜ãŸã
ãã¯0.5mgãªãã15mgã®ç¯å²ã§ãããä¿æéã0.1
mgïŒmlãäžãŸãããšèªå·±æäœããã³ïŒãŸãã¯å ç«
è€åäœã®åžçéã極床ã«äœäžãããã30mgïŒmlã
äžãŸãããšåžçç¹ç°æ§ãäœäžã奜ãŸãããªãã æ¬çºæã«äœ¿çšããèªå·±æäœããã³ïŒãŸãã¯å ç«
è€åäœã®åžçè£ çœ®ã¯ãäžè¿°ã®åŠãèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœã®åžçæããäœæ¶²ã®å°åºå ¥
å£ãåãã容åšå ã«å å¡«ä¿æãããŠãªããã®ã§ã
ãã 第ïŒå³ã«ãããŠãïŒã¯æ¬çºæã«äœ¿çšããèªå·±æ
äœããã³ïŒãŸãã¯å ç«è€åäœã®åžçè£ çœ®ã®ïŒäŸã
瀺ããã®ã§ãããåçïŒã®äžç«¯éå£éšã«ãå åŽã«
ãã€ã«ã¿ãŒïŒã匵ã€ããããã³ã°ïŒãä»ããŠäœæ¶²
å°å ¥å£ïŒãæãããã€ããïŒãããžåµåããåç
ïŒã®ä»ç«¯éå£éšã«å åŽã«ãã€ã«ã¿ãŒïŒâ²ã匵ã€ã
ãããã³ã°ïŒâ²ãä»ããŠäœæ¶²å°åºå£ïŒãæããã
ã€ããïŒãããžåµåããŠå®¹åšã圢æãããã€ã«ã¿
ãŒïŒããã³ïŒâ²ã®éãã«åžçæãå å¡«ä¿æãããŠ
åžçæå±€ïŒã圢æããŠãªããã®ã§ããã åžçæå±€ïŒã«ã¯ãæ¬çºæã®è©²åžçæãåç¬ã§å
å¡«ããŠããããä»ã®åžçæãšæ··åãããã¯ç©å±€ã
ãŠããããä»ã®åžçæãšããŠã¯ãäŸãã°DNAç
ã®ä»ã®æªæ§ç©è³ªïŒæåïŒã®åžçæããå¹ åºãåžç
èœãæãã掻æ§ççãçšããããšãã§ããããã
ã«ããåžçæã®çžä¹å¹æã«ããããåºç¯ãªèšåºå¹
æãæåŸ ã§ãããåžçæå±€ïŒã®å®¹ç©ã¯ãäœå€åŸªç°
ã«çšããå Žåã50ã400mlçšåºŠãé©åœã§ããã æ¬çºæã®è£ 眮ãäœå€åŸªç°ã§çšããå Žåã«ã¯ã倧
ç¥æ¬¡ã®äºéãã®æ¹æ³ããããäžã€ã«ã¯ãäœå ãã
åãåºããè¡æ¶²ãé å¿åé¢æ©ãããã¯èåè¡æŒ¿å
é¢åšã䜿çšããŠãè¡æŒ¿æåã®è¡çæåãšã«åé¢ã
ãåŸãè¡æŒ¿æåãè©²è£ çœ®ã«ééãããæµåãã
åŸãè¡çæåãšåãããŠäœå ã«ãã©ãæ¹æ³ã§ã
ããä»ã®äžã€ã¯äœå ããåãåºããè¡æ¶²ãçŽæ¥è©²
è£ çœ®ã«ééãããæµåããæ¹æ³ã§ããã ãŸããè¡æ¶²ãããã¯è¡æŒ¿ã®ééé床ã«ã€ããŠ
ã¯ã該åžçæã®åžçèœçãéåžžã«é«ããããåžç
æã®ç²åºŠãç²ãããããšãã§ãããŸãå 填床ãäœ
ãã§ããã®ã§ãåžçæå±€ã®åœ¢ç¶ã®åŠäœã«ãããã
ãªããé«ãééé床ãäžããããšãã§ããããã®
ããå€éã®äœæ¶²åŠçãããããšãã§ããã äœæ¶²ã®é液æ¹æ³ãšããŠã¯ãèšåºäžã®å¿ èŠã«å¿
ãããããã¯èšåã®è£ 眮ç¶æ³ã«å¿ããŠãé£ç¶çã«
é液ããŠããããããŸãæç¶çã«é液䜿çšããŠã
ããã æ¬çºæã®æ¹æ³ã¯ã以äžè¿°ã¹ãŠããããã«ãäœæ¶²
äžã®èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãé«çã
ã€ç¹ç°çã«åžçé€å»ããéåžžã«ã³ã³ãã¯ãã§ãã
ãšå ±ã«ç°¡äŸ¿ãã€å®å šã§ããããŸããæ» èæäœã容
æãã€ç¢ºå®ã«å®æœã§ãããšããã¡ãªããã䜵ãã
ã€ãŠããã æ¬çºæã¯ãèªå·±è¡æŒ¿çã®äœæ¶²ãæµåãåçãã
äžè¬çãªçšæ³ã«é©çšå¯èœã§ãããçäœå ç«æ©èœã«
é¢ä¿ããçŸæ£ã®å®å šã§ç¢ºå®ãªæ²»çãç¹ã«æ ¢æ§é¢ç¯
ãªãŠãããå šèº«æ§ãšãªããããŒãã¹çã®èªå·±å ç«
çŸæ£ã®æ²»çã«æå¹ã§ããã ãŸããæ¬çºæã®åžçæã¯ãè£ çœ®ã«å å¡«ããŠæ²»ç
åšãšããŠçšããããã«ãšã©ãŸãããã€ã ãã°ãã
ãªã³ãèªå·±æäœãã€ã ãã°ãããªã³èªå°äœãã€ã
ãã°ãããªã³è€åäœã®åé¢ã粟補çšåžçæããã³
ãããã®æž¬å®çšåºæãšããŠã極ããŠæå¹ã«å©çšã§
ããã 以äžãå®æœäŸã«ãããæ¬çºæã®å®æœã®æ æ§ãã
ã詳现ã«èª¬æããã åèäŸ ïŒ CNBr掻æ§åã»ãã¢ããŒãº4BïŒã¹ãŠãšãŒãã³ã
ãã¢ã«ãã·ã¢ç€Ÿè£œãå¹³åç²åŸ260ÎŒïŒã«ãéåžžã®
æ¹æ³ã«ãã€ãŠåçš®ã®è³éŠæç°ããã³çæ°Žæ§ã¢ãã
é žãŸãã¯ãã®èªå°äœãå«ãçæ°Žæ§ååç©ãçµåã
ãããéå°ã®æŽ»æ§åºããšã¿ããŒã«ã¢ãã³ã§ããã
ãã³ã°ãããä¿æéã¯ãæ®äœçæ°Žæ§ååç©ã®ïŒçŽ
ã¢ããåºãïŒâããšãã«ã¹ããããã©ã³âïŒ
ïŒ3HïŒïŒ1â²âãã¿ã©ã³ãâïŒïŒ3â²âãžãªã³ïŒâãã«ã©
ã âãã·ãŠç€Ÿè£œïŒãšåå¿çµåããã475ã490n
ïœã®èå ïŒå±èµ·æ³¢390nïœïŒã§æž¬å®ããå¥ã«æªæŽ»
æ§åã»ãã¢ããŒãº4Bã§å®éšããç©çåžçéãã
ãåŒããŠç®åºããã ãšã¿ããŒã«ã¢ãã³ããããã³ã°åŸã®åžçæãã
PHïŒâ0.1Mé ¢é žãããã¢ãŒãPH8.5â0.1MããŠé ž
ãããã¢ãŒã§ããè¿ãæŽæµåŸãççé£å¡©æ°Žã§æŽ
æµãæ°ŽåãããŠå®éšã«äŸããã åžçå®éšã¯ãããè¡æŒ¿ïŒå®¹ãšåžçæïŒå®¹ãæ··å
ãã37âãïŒæéã€ã³ããŠããŒããããåžçåŸã®
ã°ãããªã³ãã¢ã«ããã³éãïŒïŒ§ãã¹ãããã
ãïŒGBãã¹ã ã¯ã³ãŒãåå çŽè¬å·¥æ¥(æ ª)補ã
ã«ãŠæž¬å®ããããŸããæªæŽ»æ§åã»ãã¢ããŒãºãçš
ããŠåžçå®éšãè¡ããã³ã³ãããŒã«ãšãããçµæ
ãè¡šâïŒã«ç€ºãããè¡šâïŒããå°ãªããšãïŒã€ã®
è³éŠæç°ãå«ãçæ°Žæ§ååç©ããç¹ç°çãã€é«ç
ã«ã°ãããªã³ãåžçããããšãæããã§ããã
å¯æ¥ãªé¢ä¿ããã€ãšèããããŠããèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœãç¹ç°çã«åžçé€å»ããã
è¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ã«é¢ããã åšç¥ã®åŠããè¡æ¶²äžã«çºçŸããèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœã¯ãçãå ç«å¢æ®æ§çå
矀ãæ ¢æ§é¢ç¯ãªãŠãããå šèº«æ§ãšãªããããŒãã¹
çã®èªå·±å ç«çŸæ£ããããã¯ã¢ã¬ã«ã®ãŒãèåšç§»
æ€æã®æ絶åå¿çã®çäœå ç«æ©èœã«é¢ä¿ããçŸæ£
ããã³çŸè±¡ã®åå ãããã¯é²è¡ãšå¯æ¥ãªé¢ä¿ãã
ã€ãŠãããšèããããŠããã ããã§ãè¡æ¶²ãè¡æŒ¿çã®äœæ¶²æåãããäžèšèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœãç¹ç°çã«åžç
é€å»ããããšã«ãã€ãŠãäžèšã®åŠãçŸæ£ã®é²è¡ã
é²æ¢ããçç¶ã軜æžããããããã«ã¯æ²»çãæ©ã
ãããšãæåŸ ãããŠããã åŸæ¥ããã®ãããªç®çã«äŸãåŸãåžçæãšããŠ
ã¯ããããã€ã³ïŒ¡ãäžæº¶æ§æ äœã«åºå®ãããåžç
æãã¢ã¯ãªã«é žãšã¹ãã«ç³»å€åæ§æš¹èïŒäŸãã°
XADâïŒãããŒã ã¢ã³ãããŒã¹ç€Ÿè£œïŒãããã¯
ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹çã®éœã€ãªã³äº€æäœ
ãææ¡ãããŠããã ããããªããããããã€ã³ïŒ¡ãäžæº¶æ§æ äœã«åº
å®ãããåžçæã¯ãèªå·±æäœããã³ïŒãŸãã¯å ç«
è€åäœã«å¯Ÿãç¹ç°çåžçæ©èœãæãããã®ã®ãé»
è²ãããŠçèç±æ¥ã®çç掻æ§ã¿ã³ãã¯è³ªã§ããã
ããåæ確ä¿ãå°é£ã§è£œåã³ã¹ããããããšãã
äžå©ç¹ãããããŸãã掻æ§ãäžå®å®ãªãããåºå®
åæã®åãæ±ããåºå®ååŸã®ä¿åçã«ãã倱掻ã
èµ·ããæãæ¬ ç¹ããããããã«ãäœæ¶²ã«æ¥è§Šãã
ããŠäœ¿çšããéã«ããããã€ã³ïŒ¡æº¶åºã«ããåŒå®³
ãçããå±éºããããå ããŠã倱掻ãæãã€ã€æ»
èããããšãå°é£ã§ãããšããé£ç¹ããã€ãã ãŸããã¢ã¯ãªã«é žãšã¹ãã«ç³»å€åæ§æš¹èããã³
ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã¯ãåžçèœãå°ã
ãããã®äžãåžçç¹ç°æ§ãäœããšããæ¬ ç¹ãã
ããããã«äœæ¶²äžã®ã¢ã«ããã³ããåžçããã®
ã§ã浞éå§ã®ç°åžžãããããå®å šãªæ²»çåšãšããŠ
å©çšããããšã¯äžå¯èœã§ãã€ãã æ¬çºæã®ç®çã¯ãäžèšã®åŠãåŸæ¥æè¡ã«åºã¥ã
èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®åžçæã®å
é¡ç¹ã«éã¿ãäžè¬çã«æ®åå¯èœã§ãããèªå·±æäœ
ããã³ïŒãŸãã¯å ç«è€åäœãé«æŽ»æ§ãã€ç¹ç°çã«
åžçããå®å®ãªæŽ»æ§ãä¿æããå®å šæ§ããããæ»
èæäœãç°¡æã«è¡ãããšãã§ããäœæ¶²æµåããã
ã¯åççšã«é©ããåžçæãå©çšããŠãèªå·±æäœã
ãã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»ãããè¡
液ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ãæäŸãããšããã
ã®ã§ããã æ¬çºæè ãã¯ãäžèšç®çã«æ²¿ã€ãŠéæç 究ãã
çµæãåçš®ã®ååç©ãäžæº¶æ§æ äœã«çµåããèªå·±
æäœããã³å ç«è€åäœã«å¯Ÿããçµå掻æ§ãè©äŸ¡ã
ããšãããå®ã«é©ãã¹ãããšã«ã¯ãäžæº¶æ§æ äœã
çµåããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœããã¢
ã«ããã³ãã»ãšãã©åžçããã極ããŠé«æŽ»æ§ãã€
ç¹ç°çã«èªå·±æäœãå ç«è€åäœãåžçããããšã
èŠåºããæ¬çºæãå®æããã«è³ã€ãã ããªãã¡ãæ¬çºæã¯ã25âã«ããã察ççé£å¡©
氎溶解床ã100ïœmolïŒdl以äžã§ããçæ°Žæ§ã¢ã
ãé žãŸãã¯ãã®èªå°äœããã³ïŒãŸãã¯è©²çæ°Žæ§ã¢
ããé žãŸãã¯ãã®èªå°äœãå«ããªãªãŽããŒãæ°Žäž
溶æ§æ äœïŒmlããã0.1ã30mgçµåãããŠãªãåž
çæã«ãèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãå ±
åããè¡æ¶²ãŸãã¯è¡æŒ¿ãæµãããšãç¹åŸŽãšããèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»
ãããè¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ã«ä¿ãã æ¬çºæã§å¯Ÿè±¡ãšããåžçç©è³ªã¯ãèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœã§ãããããã詳现ã«èª¬æ
ãããšããªãŠããå åãææ žæäœãæDNAæäœã
æãªã³ãçæäœãæèµ€è¡çæäœãæè¡å°æ¿æäœã
ã¢ã»ãã«ã³ãªã³ã¬ã»ãã¿ãŒæäœãè¡æž è±é«æäœã
æãµã€ãã°ãããªã³æäœãæãã€ã¯ããŸãŒã æ
äœãæå€§è žæäœçã®èªå·±æäœãèªå·±æäœã®éå ç
æç©ãååŠä¿®é£Ÿçæç©çã®ã€ã ãã°ãããªã³èªå°
äœãèªå·±æäœéãŸãã¯èªå·±æäœãšä»ã®ç©è³ªãç¹ã«
æåããã³æåæ§ç©è³ªãšã®è€åäœçã§ããããã
ãã®äžã§ãç¹ã«æ¬çºæã®å¯Ÿè±¡ãšããåžçç©è³ªãšã
ãŠå¥œãŸãããã®ã¯ãèªå·±å ç«çŸæ£ã®åå ããã³é²
è¡ãšæ·±ãé¢ããããã€èªå·±æäœããã³å ç«è€åäœ
ã§ããã æ¬çºæã«çšããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°
äœãšã¯ã察ççé£å¡©æ°Žæº¶è§£åºŠ100ããªã¢ã«ïŒdl以
äžïŒ25âïŒããã奜ãŸããã¯30ããªã¢ã«ïŒdl以äž
ã®ååç©ãããã察ççé£å¡©æ°Žæº¶è§£åºŠã100ããª
ã¢ã«ïŒdlãã倧ããååç©ã¯ã芪氎æ§ãé«ããªã
ãããèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœã«å¯Ÿã
ã芪ååãäœäžããçµæãåžçèœã極端ã«äœäžã
ãããŸãããã芪氎çãªã¢ã«ããã³ã«å¯Ÿãã芪å
åãçããŠãã¢ã«ããã³ããéç¹ç°çã«åžçãã
ããã«ãªã奜ãŸãããªãã çæ°Žæ§ã¢ããé žããã³ãã®èªå°äœãšã¯ã
Tanford.NozakiïŒJ.Am.Chem.Soc.ã184 4240
ïŒ1962ïŒãJ.Biol.Chem.246 2211ïŒ1971ïŒïŒãã¿ã³ã
ãªãŒãããã¶ãïŒãžã€ãŒãã«ã»ãªãã»ã¢ã¡ãªã«
ã³ã»ã±ãã«ã«ã»ãœãµãšãã€ã184ã4240ïŒ1962ïŒã
ãžã€ãŒãã«ã»ãªãã»ãã€ãªããžã«ã«ã»ã±ãã¹ããª
ã€246ã2211ïŒ1971ïŒãã«ããå®çŸ©ãããçæ°Žæ§å°º
床ã§ã¿ãŠã1500calïŒmol以äžã®ã¢ããé žããã³
ãã®èªå°äœã§ã察ççé£å¡©æ°Žæº¶è§£åºŠ100ããªã¢
ã«ïŒdl以äžã®ååç©ãæå³ãããäŸãã°ããªãž
ã³ãããªã³ããã€ã·ã³ãããã·ã³ãããšãã«ã¢ã©
ãã³ãã€ãœãã€ã·ã³ãããªãããã¢ã³ããã³ãã®
èªå°äœçã§ããããããã®çæ°Žæ§ã¢ããé žããã³
ãã®èªå°äœã®äžã§ã¯ãããªãããã¢ã³ããã³ãã®
èªå°äœãç¹ã«è¯å¥œãªçµæãäžããããŸããã¢ãã
é žã¯ïœãïœã®ç«äœé 座ãç¹ã«éå®ããããšãªã䜿
çšããããšãã§ããã çæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœã®ãã¡ãäžæº¶
æ§æ äœã«çµåããç¶æ ã§é解é£æ§ãäž¡ã€ãªã³æ§ã
ã«ããªã³æ§ã®ååç©ããèªå·±æäœããã³ïŒãŸãã¯
å ç«è€åäœãããéžæçã«åžçããã®ã§ãã¢ããª
ã³æ§ã®ååç©ããã¯å¥œãŸãããã¢ããªã³æ§ã®åå
ç©ã¯ãã¢ã«ããã³ååãèªå·±æäœããã³å ç«è€å
äœããé»æ°çã«é°æ§ã§ããããšããåœç¶äºæ³ãã
ãçµæã«åããŠãã¢ã«ããã³ã«èŠªåæ§ã§ãããèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®åžçéãäœäž
ãããäŸãã°ãããšãã«ã¢ã©ãã³ã¡ãã«ãšã¹ã
ã«ãããšãã«ã¢ã©ãã³ãããã·ã³ã¯ããã®çæ°Žæ§
ã«å€§ããªçžéããªããããã®ã¢ããåºã§äžæº¶æ§æ
äœã«å ±æçµåããèªå·±æäœåžçèœãè©äŸ¡ããæã
ããšãã«ã¢ã©ãã³ã¡ãã«ãšã¹ãã«ïŒããšãã«ã¢ã©
ãã³ããã·ã³ã®åºåã«ãªããããšãã«ã¢ã©ã
ã³ãããã·ã³ã¯ãåžçèœãäœäžããããšã«ãã®å®
äŸãã¿ãããšãã§ããããŸããéè³éŠæååç©ã
åæ§ã®çµæã瀺ãããç¹ã«ã¢ããªã³æ§åºãšããŠã
ã¹ã«ããªã³é žåºãæãããã芪氎æ§ããååç©
ã¯ãèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœããã¢ã«
ããã³ã«èŠªåçã§ãããã¢ã«ããã³åžçæãšããŠ
äœçšãããããã¯ååç©ã®é»è·ãšã¢ã«ããã³ãå
åå ã®ãã¯ããªç°å¢ã®é»è·ãšã®çžäºäœçšã«ããã
ã®ãšæšå®ãããã 以äžã®å®éšçµæããã¿ãŠãæ¬çºæã®äœçšã¡ã«ã
ãºã ã¯ãäžæº¶æ§æ äœã«çµåããçæ°Žæ§ååç©ãšèª
å·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®çæ°Žæ§çžäºäœ
çšåïŒVan der WaalsåïŒã«åºã¥ããã®ãšèã
ãããããŸããé éåãšããŠã®é»è·éçžäºäœçšå
ïŒã¯ãŒãã³åïŒãäºæ¬¡çã«äœçšããŠãããã®ãšæš
å®ãããã æ¬çºæã®çæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœãå«
ããªãªãŽããŒã¯ãååé1000以äžã®ãªãªãŽããŒã§
ãããããã«ãããããã€ã³ïŒ¡ïŒååé42000ïŒã®
ãããªå€©ç¶é«ååã«æ¯èŒããŠåºå®åæã®åãæ±
ããåºå®ååŸã®ä¿åã容æã«è¡ãããã®ã§ããã
ãŸããåœè©²ç©è³ªãäžæº¶æ§æ äœãã溶åºããå Žåã«
ããååéïŒäžä»¥äžã®ãªãªãŽããŒã¯ãçäœã«å¯Ÿã
ãæåæ§ãç¡èŠã§ããã»ã©å°ããå®å šã§ãããæ»
èæäœã容æã«è¡ãããã®ã§ããã該ãªãªãŽããŒ
ã¯ãçæ°Žæ§ååç©ã¢ãããŒåç¬ãŸãã¯ä»ã®ååç©
ãšã®å ±éåã«ããåŸããããçæ°Žæ§ã¢ããé žãŸã
ã¯ãã®èªå°äœã¢ãããŒãšããŠã¯ãäŸãã°ãããªã
ããã¢ã³çãçšããããšãã§ããã æ¬çºæã§çšããããäžæº¶æ§æ äœã¯ã芪氎æ§æ
äœãçæ°Žæ§æ äœãããã䜿çšã§ããããçæ°Žæ§æ
äœãçšããå Žåã«ã¯ãæã«æ äœãžã®ã¢ã«ããã³ã®
éç¹ç°çåžçãçããããã芪氎æ§æ äœã®æ¹ã奜
ãŸããçµæãäžããã äžæº¶æ§æ äœã®åœ¢ç¶ã¯ãç²åç¶ãç¹ç¶ç¶ãäžç©ºç³ž
ç¶ãèç¶çãããã®å ¬ç¥ã®åœ¢ç¶ãçšãããããç
æ°Žæ§ååç©ã®ä¿æéãåžçæãšããŠã®åãæ±ãæ§
ããã¿ãŠãç²åç¶ãç¹ç¶ç¶ã®ãã®ã奜ãŸããã ç²åç¶æ äœãšããŠã¯ãå¹³åç²åŸ150ÎŒãªãã
2500ÎŒã®ç¯å²ã«ããããšã奜ãŸãããå¹³åç²åŸã¯
JISââ8801ã«èŠå®ããããã«ã€ãçšããŠæµæ°Ž
äžã§åçŽããåŸãåçŽã®äžéç²åŸãšäžéç²åŸã®äž
éå€ãåçŽã®ç²åŸãšãããã®ééå¹³åãšããŠå¹³å
ç²åŸãç®åºããããŸããç²å圢ç¶ã¯ç圢ã奜ãŸã
ãããç¹ã«éå®ããããã®ã§ã¯ãªããå¹³åç²åŸã
2500Ό以äžã§ã¯ãèªå·±æäœããã³ïŒãŸãã¯å ç«è€
åäœã®åžçéåã³åžçé床ãäœäžãããã150ÎŒ
以äžã§ã¯ãååºç³»ã®æŽ»æ§åãè¡çç²çããããã
ããã䜿ãããç²åç¶æ äœãšããŠã¯ãã¢ã¬ããŒã¹
ç³»ãããã¹ãã©ã³ç³»ãã»ã«ããŒã¹ç³»ãããªã¢ã¯ãª
ã«ã¢ããç³»ãã¬ã©ã¹ç³»ã掻æ§çç³»ã®æ äœã§ãã
ããã²ã«æ§é ãæãã芪氎æ§æ äœãè¯å¥œãªçµæã
äžããããŸããéåžžåºå®åé µçŽ ãã¢ãã€ããã€ã¯
ãããã°ã©ãã€ã«çšããããå ¬ç¥ã®æ äœã¯ãç¹å¥
ãªéå®ãªã䜿çšããããšãã§ããã ç²åç¶æ äœãšããŠã¯ãå€åæ§ç²åãç¹ã«å€åæ§
éåäœãçšããããšãã§ãããæ¬çºæã§çšããã
ãå€åæ§éåäœç²åã¯ããã®è¡šé¢ã«çæ°Žæ§ååç©
ãåºå®åããããã®ã§ãããå¹³ååç³»300â«ãªã
ã9000â«ããã奜ãŸããã¯1000â«ãªãã6000â«ã®
ç¯å²ã«ãããã®ã§ãããéåäœçµæã¯ãããªã¢ã
ãç³»ãããªãšã¹ãã«ç³»ãããªãŠã¬ã¿ã³ç³»ãããã«
ååç©ã®éåäœçãå€åæ§æ§é ããšãããå ¬ç¥ã®
éåäœãçšããããšãã§ããããç¹ã«èŠªæ°Žæ§ã¢ã
ããŒã«ãã芪氎åããããã«ååç©ç³»å€åæ§éå
äœç²åã奜ãŸããçµæãäžããã 該å€åæ§æ§é ã¯ãå¹³åç²åŸ300â«ãªãã9000â«
ç¯å²ã«ããã®ã奜ãŸããããå¹³åååŸãå°ããã
ãå Žåã«ã¯ãåžçãããèªå·±æäœããã³ïŒãŸãã¯
å ç«è€åäœã®éãå°ãªãã倧ããããå Žåã«ã¯ã
éåäœç²åã®åŒ·åºŠãäœäžãããã€è¡šé¢ç©ãæžå°ã
ãããå®çšçã§ã¯ãªãã å¹³åååŸã®æž¬å®ã¯æ°Žéå§å ¥åŒããã·ã¡ãŒã¿ãŒã«
ãã€ãããã®æ¹æ³ã¯ãå€åæ§ç©è³ªã«æ°Žéãå§å ¥ã
ãŠãããæµžå ¥ããæ°Žééããæ°åéããå§å ¥ã«èŠ
ããå§åããååŸãæ±ããæ¹æ³ã§ããã40â«ä»¥äž
ã®åã枬å®ããããšãã§ãããæ¬çºæã®åãšã¯ã
ååŸã40â«ä»¥äžã®è¡šé¢ããã®é£éåãšå®çŸ©ããã
å¹³åååŸã¯ãååŸãïœãããã·ã¡ãŒã¿ãŒã§æž¬å®ã
ã环ç©æ°åéããšãããšããdVïŒïœ log ïœ
ã®å€ãæ倧ãšãªããšãã®ïœã®å€ãšããã ç¹ç¶ç¶æ äœãçšããå Žåã«ã¯ããã®ç¹ç¶åœ¢ã
0.02ãããŒã«ãªãã10ãããŒã«ããã奜ãŸããã¯
0.1ãããŒã«ãªããïŒãããŒã«ã®ç¯å²ã«ãããã®
ãè¯ããç¹ç¶åŸã倧ããããå Žåã«ã¯ãèªå·±æäœ
ããã³ïŒãŸãã¯å ç«è€åäœã®åžçéããã³åžçé
床ãäœäžããããå°ããããå Žåã«ã¯ãååºç³»ã®
掻æ§åãè¡çç²çãç®ã¥ãŸãããããããããçš
ãããç¹ç¶ç¶æ äœãšããŠã¯ãåçã»ã«ããŒã¹ç³»ç¹
ç¶ããã€ãã³ãã¢ã¯ãªã«ãããªãšãã«çå ¬ç¥ã®ç¹
ç¶ãäžè¬ã«çšããããšãã§ããã çæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœãäžæº¶æ§æ äœ
ã®è¡šé¢ã«åºå®ããæ¹æ³ã¯ãå ±æçµåãã€ãªã³çµ
åãç©çåžçãå åãããã¯éåäœè¡šé¢ãžã®æ²æŸ±
äžæº¶åçããããå ¬ç¥ã®æ¹æ³ãçšããããšãã§ã
ãããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èªå°äœã®æº¶åºæ§
ããèãããšãå ±æçµåã«ãããåºå®ãäžæº¶åã
ãŠçšããããšã奜ãŸããããã®ããéåžžåºå®åé µ
çŽ ãã¢ãã€ããã€ã¯ãããã°ã©ãã€ã§çšãããã
å ¬ç¥ã®äžæº¶æ§æ äœã®æŽ»æ§åæ¹æ³ããã³çæ°Žæ§åå
ç©ãšã®çµåæ¹æ³ãçšããããšãã§ããããŸããå¿
èŠã«å€§ããŠäžæº¶æ§æ äœãšçæ°Žæ§ã¢ããé žãŸãã¯ã
ã®èªå°äœã®éã«ä»»æã®é·ãã®ååïŒã¹ããŒãµãŒïŒ
ãå°å ¥ããŠäœ¿çšããããšãã§ãããäŸãã°ãã¢ã¬
ããŒã¹ã®ããããã·ã«åºãšãããµã¡ãã¬ã³ãžã€ãœ
ã·ã¢ããŒãã®çåŽã®ã€ãœã·ã¢ããŒãåºãåå¿ãçµ
åãããæ®ã€ãã€ãœã·ã¢ããŒãåºãšçæ°Žæ§ã¢ãã
é žãŸãã¯ãã®èªå°äœã®ã¢ããåºãããããã·ã«
åºãã¹ã«ããããªã«åºãã«ã«ããã·ã«åºçãå
å¿ãçµåãããããšãå®æœããããšãã§ãããã¹
ããŒãµãŒé·ããšããŠã¯ãã¹ããŒãµãŒã®ãªããã®ã
ãããã®äžã«å«ãŸããååæ°ã§20ãŸã§ãç¹ã«å¥œãŸ
ããçµæãäžããã æ¬çºæã§äžæº¶æ§æ äœã«çµåããŠããçæ°Žæ§ã¢ã
ãé žãŸãã¯ãã®èªå°äœã®éã¯ãäžæº¶æ§æ äœïŒmlåœ
ãã0.1mgãªãã30mgã®ç¯å²ã§ããããã奜ãŸã
ãã¯0.5mgãªãã15mgã®ç¯å²ã§ãããä¿æéã0.1
mgïŒmlãäžãŸãããšèªå·±æäœããã³ïŒãŸãã¯å ç«
è€åäœã®åžçéã極床ã«äœäžãããã30mgïŒmlã
äžãŸãããšåžçç¹ç°æ§ãäœäžã奜ãŸãããªãã æ¬çºæã«äœ¿çšããèªå·±æäœããã³ïŒãŸãã¯å ç«
è€åäœã®åžçè£ çœ®ã¯ãäžè¿°ã®åŠãèªå·±æäœãã
ã³ïŒãŸãã¯å ç«è€åäœã®åžçæããäœæ¶²ã®å°åºå ¥
å£ãåãã容åšå ã«å å¡«ä¿æãããŠãªããã®ã§ã
ãã 第ïŒå³ã«ãããŠãïŒã¯æ¬çºæã«äœ¿çšããèªå·±æ
äœããã³ïŒãŸãã¯å ç«è€åäœã®åžçè£ çœ®ã®ïŒäŸã
瀺ããã®ã§ãããåçïŒã®äžç«¯éå£éšã«ãå åŽã«
ãã€ã«ã¿ãŒïŒã匵ã€ããããã³ã°ïŒãä»ããŠäœæ¶²
å°å ¥å£ïŒãæãããã€ããïŒãããžåµåããåç
ïŒã®ä»ç«¯éå£éšã«å åŽã«ãã€ã«ã¿ãŒïŒâ²ã匵ã€ã
ãããã³ã°ïŒâ²ãä»ããŠäœæ¶²å°åºå£ïŒãæããã
ã€ããïŒãããžåµåããŠå®¹åšã圢æãããã€ã«ã¿
ãŒïŒããã³ïŒâ²ã®éãã«åžçæãå å¡«ä¿æãããŠ
åžçæå±€ïŒã圢æããŠãªããã®ã§ããã åžçæå±€ïŒã«ã¯ãæ¬çºæã®è©²åžçæãåç¬ã§å
å¡«ããŠããããä»ã®åžçæãšæ··åãããã¯ç©å±€ã
ãŠããããä»ã®åžçæãšããŠã¯ãäŸãã°DNAç
ã®ä»ã®æªæ§ç©è³ªïŒæåïŒã®åžçæããå¹ åºãåžç
èœãæãã掻æ§ççãçšããããšãã§ããããã
ã«ããåžçæã®çžä¹å¹æã«ããããåºç¯ãªèšåºå¹
æãæåŸ ã§ãããåžçæå±€ïŒã®å®¹ç©ã¯ãäœå€åŸªç°
ã«çšããå Žåã50ã400mlçšåºŠãé©åœã§ããã æ¬çºæã®è£ 眮ãäœå€åŸªç°ã§çšããå Žåã«ã¯ã倧
ç¥æ¬¡ã®äºéãã®æ¹æ³ããããäžã€ã«ã¯ãäœå ãã
åãåºããè¡æ¶²ãé å¿åé¢æ©ãããã¯èåè¡æŒ¿å
é¢åšã䜿çšããŠãè¡æŒ¿æåã®è¡çæåãšã«åé¢ã
ãåŸãè¡æŒ¿æåãè©²è£ çœ®ã«ééãããæµåãã
åŸãè¡çæåãšåãããŠäœå ã«ãã©ãæ¹æ³ã§ã
ããä»ã®äžã€ã¯äœå ããåãåºããè¡æ¶²ãçŽæ¥è©²
è£ çœ®ã«ééãããæµåããæ¹æ³ã§ããã ãŸããè¡æ¶²ãããã¯è¡æŒ¿ã®ééé床ã«ã€ããŠ
ã¯ã該åžçæã®åžçèœçãéåžžã«é«ããããåžç
æã®ç²åºŠãç²ãããããšãã§ãããŸãå 填床ãäœ
ãã§ããã®ã§ãåžçæå±€ã®åœ¢ç¶ã®åŠäœã«ãããã
ãªããé«ãééé床ãäžããããšãã§ããããã®
ããå€éã®äœæ¶²åŠçãããããšãã§ããã äœæ¶²ã®é液æ¹æ³ãšããŠã¯ãèšåºäžã®å¿ èŠã«å¿
ãããããã¯èšåã®è£ 眮ç¶æ³ã«å¿ããŠãé£ç¶çã«
é液ããŠããããããŸãæç¶çã«é液䜿çšããŠã
ããã æ¬çºæã®æ¹æ³ã¯ã以äžè¿°ã¹ãŠããããã«ãäœæ¶²
äžã®èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãé«çã
ã€ç¹ç°çã«åžçé€å»ããéåžžã«ã³ã³ãã¯ãã§ãã
ãšå ±ã«ç°¡äŸ¿ãã€å®å šã§ããããŸããæ» èæäœã容
æãã€ç¢ºå®ã«å®æœã§ãããšããã¡ãªããã䜵ãã
ã€ãŠããã æ¬çºæã¯ãèªå·±è¡æŒ¿çã®äœæ¶²ãæµåãåçãã
äžè¬çãªçšæ³ã«é©çšå¯èœã§ãããçäœå ç«æ©èœã«
é¢ä¿ããçŸæ£ã®å®å šã§ç¢ºå®ãªæ²»çãç¹ã«æ ¢æ§é¢ç¯
ãªãŠãããå šèº«æ§ãšãªããããŒãã¹çã®èªå·±å ç«
çŸæ£ã®æ²»çã«æå¹ã§ããã ãŸããæ¬çºæã®åžçæã¯ãè£ çœ®ã«å å¡«ããŠæ²»ç
åšãšããŠçšããããã«ãšã©ãŸãããã€ã ãã°ãã
ãªã³ãèªå·±æäœãã€ã ãã°ãããªã³èªå°äœãã€ã
ãã°ãããªã³è€åäœã®åé¢ã粟補çšåžçæããã³
ãããã®æž¬å®çšåºæãšããŠã極ããŠæå¹ã«å©çšã§
ããã 以äžãå®æœäŸã«ãããæ¬çºæã®å®æœã®æ æ§ãã
ã詳现ã«èª¬æããã åèäŸ ïŒ CNBr掻æ§åã»ãã¢ããŒãº4BïŒã¹ãŠãšãŒãã³ã
ãã¢ã«ãã·ã¢ç€Ÿè£œãå¹³åç²åŸ260ÎŒïŒã«ãéåžžã®
æ¹æ³ã«ãã€ãŠåçš®ã®è³éŠæç°ããã³çæ°Žæ§ã¢ãã
é žãŸãã¯ãã®èªå°äœãå«ãçæ°Žæ§ååç©ãçµåã
ãããéå°ã®æŽ»æ§åºããšã¿ããŒã«ã¢ãã³ã§ããã
ãã³ã°ãããä¿æéã¯ãæ®äœçæ°Žæ§ååç©ã®ïŒçŽ
ã¢ããåºãïŒâããšãã«ã¹ããããã©ã³âïŒ
ïŒ3HïŒïŒ1â²âãã¿ã©ã³ãâïŒïŒ3â²âãžãªã³ïŒâãã«ã©
ã âãã·ãŠç€Ÿè£œïŒãšåå¿çµåããã475ã490n
ïœã®èå ïŒå±èµ·æ³¢390nïœïŒã§æž¬å®ããå¥ã«æªæŽ»
æ§åã»ãã¢ããŒãº4Bã§å®éšããç©çåžçéãã
ãåŒããŠç®åºããã ãšã¿ããŒã«ã¢ãã³ããããã³ã°åŸã®åžçæãã
PHïŒâ0.1Mé ¢é žãããã¢ãŒãPH8.5â0.1MããŠé ž
ãããã¢ãŒã§ããè¿ãæŽæµåŸãççé£å¡©æ°Žã§æŽ
æµãæ°ŽåãããŠå®éšã«äŸããã åžçå®éšã¯ãããè¡æŒ¿ïŒå®¹ãšåžçæïŒå®¹ãæ··å
ãã37âãïŒæéã€ã³ããŠããŒããããåžçåŸã®
ã°ãããªã³ãã¢ã«ããã³éãïŒïŒ§ãã¹ãããã
ãïŒGBãã¹ã ã¯ã³ãŒãåå çŽè¬å·¥æ¥(æ ª)補ã
ã«ãŠæž¬å®ããããŸããæªæŽ»æ§åã»ãã¢ããŒãºãçš
ããŠåžçå®éšãè¡ããã³ã³ãããŒã«ãšãããçµæ
ãè¡šâïŒã«ç€ºãããè¡šâïŒããå°ãªããšãïŒã€ã®
è³éŠæç°ãå«ãçæ°Žæ§ååç©ããç¹ç°çãã€é«ç
ã«ã°ãããªã³ãåžçããããšãæããã§ããã
ãè¡šã
ããã«åžçå®éšåŸã®åžçæïŒããªãã¿ãã³ïŒã»
ãã¢ããŒãº4BïŒïŒmlãçšããŠãåžçããã°ãã
ãªã³ã®ã€ã ãã°ãããªã³ã¯ã©ã¹å¥å®éãè¡ã€ãã
åžçæãæ°·å·ããPBSã§ïŒåæŽæµãè±æ°ŽåŸã50
mlãæ°·å·ãã0.1Mã°ãªã·ã³å¡©é žç·©è¡æ¶²ïŒPH2.5ïŒ
ã§åžçããã°ãããªã³ã溶é¢ããã溶é¢æ¶²ãã·ã³
ã°ã«ã©ãžã¢ã«ã€ã ããã€ããŠãŒãžãšã³ïŒSRIDïŒ
ã«ãŠã°ãããªã³ã¯ã©ã¹å¥å®éãè¡ã€ããSRIDã¯
(æ ª)å»åŠçç©åŠç 究æ補ã®ãã¬ãŒããçšãããæ€åº
ãããã°ãããªã³ã¯ã©ã¹å¥ã®éã¯ãã€ã ãã°ãã
ãªã³ïŒ§ãïŒmgãã€ã ãã°ãããªã³ïŒã0.6mgãã€
ã ãã°ãããªã³ïŒ¡ã1.4mgã§ãã€ããããã«ãã
æ¬çºæã®åžçæããã€ã ãã°ãããªã³ããã®ã¯ã©
ã¹ã«ä¿ãããªãé«æŽ»æ§ã«åžçããããšãå€ãã åèäŸ ïŒ çæ°Žæ§ååç©ãšããŠãã·ã¯ãããã·ã«ã¢ãã³ã
ãã³ã€ãœãã€ã·ã³ã¡ãã«ãšã¹ãã«ãçšããããšä»¥
å€ã¯ãåèäŸïŒãšåæ§ã«ããŠåžçå®éšãè¡ã€ããš
ãããã·ã¯ãããã·ã«ã¢ãã³ã§ã°ãããªã³åžçç
12ïŒ ãã¢ã«ããã³åžççïŒïŒ ãã€ãœãã€ã·ã³ã¡ã
ã«ãšã¹ãã«ã«ãŠã°ãããªã³åžçç25ïŒ ãã¢ã«ãã
ã³åžççïŒïŒ ãšãã€ãè¯å¥œãªçµæãåŸãããã åèäŸ ïŒ çæ°Žæ§ååç©ã®ä»£ããã«èŠªæ°Žæ§ååç©ãçšã
ãŠãåèäŸïŒãšåæ§ã®å®éšãè¡ã€ããçµæãè¡šâ
ïŒã«ç€ºããããããã芪氎æ§ååç©ããã°ãããª
ã³ã®åžçèœãåžçç¹ç°æ§ã«ãããŠèããå£ãããš
ã¯æããã§ããã
ãã¢ããŒãº4BïŒïŒmlãçšããŠãåžçããã°ãã
ãªã³ã®ã€ã ãã°ãããªã³ã¯ã©ã¹å¥å®éãè¡ã€ãã
åžçæãæ°·å·ããPBSã§ïŒåæŽæµãè±æ°ŽåŸã50
mlãæ°·å·ãã0.1Mã°ãªã·ã³å¡©é žç·©è¡æ¶²ïŒPH2.5ïŒ
ã§åžçããã°ãããªã³ã溶é¢ããã溶é¢æ¶²ãã·ã³
ã°ã«ã©ãžã¢ã«ã€ã ããã€ããŠãŒãžãšã³ïŒSRIDïŒ
ã«ãŠã°ãããªã³ã¯ã©ã¹å¥å®éãè¡ã€ããSRIDã¯
(æ ª)å»åŠçç©åŠç 究æ補ã®ãã¬ãŒããçšãããæ€åº
ãããã°ãããªã³ã¯ã©ã¹å¥ã®éã¯ãã€ã ãã°ãã
ãªã³ïŒ§ãïŒmgãã€ã ãã°ãããªã³ïŒã0.6mgãã€
ã ãã°ãããªã³ïŒ¡ã1.4mgã§ãã€ããããã«ãã
æ¬çºæã®åžçæããã€ã ãã°ãããªã³ããã®ã¯ã©
ã¹ã«ä¿ãããªãé«æŽ»æ§ã«åžçããããšãå€ãã åèäŸ ïŒ çæ°Žæ§ååç©ãšããŠãã·ã¯ãããã·ã«ã¢ãã³ã
ãã³ã€ãœãã€ã·ã³ã¡ãã«ãšã¹ãã«ãçšããããšä»¥
å€ã¯ãåèäŸïŒãšåæ§ã«ããŠåžçå®éšãè¡ã€ããš
ãããã·ã¯ãããã·ã«ã¢ãã³ã§ã°ãããªã³åžçç
12ïŒ ãã¢ã«ããã³åžççïŒïŒ ãã€ãœãã€ã·ã³ã¡ã
ã«ãšã¹ãã«ã«ãŠã°ãããªã³åžçç25ïŒ ãã¢ã«ãã
ã³åžççïŒïŒ ãšãã€ãè¯å¥œãªçµæãåŸãããã åèäŸ ïŒ çæ°Žæ§ååç©ã®ä»£ããã«èŠªæ°Žæ§ååç©ãçšã
ãŠãåèäŸïŒãšåæ§ã®å®éšãè¡ã€ããçµæãè¡šâ
ïŒã«ç€ºããããããã芪氎æ§ååç©ããã°ãããª
ã³ã®åžçèœãåžçç¹ç°æ§ã«ãããŠèããå£ãããš
ã¯æããã§ããã
ãè¡šã
å®æœäŸ ïŒ
çæ°Žæ§ååç©ãšããŠããªãããã¢ã³ãããªãã
ãã¢ã³ã¡ãã«ãšã¹ãã«ãããªãã¿ãã³ãïœâããš
ãã«ã¢ã©ãã³ã¡ãã«ãšã¹ãã«ããããè¡æŒ¿ã®ä»£ã
ãã«ããæ ¢æ§é¢ç¯ãªãŠããæ£è è¡æŒ¿ãçšãã以å€
ã¯ãåèäŸïŒãšåæ§ãå®éšãè¡ã€ããæ ¢æ§é¢ç¯ãª
ãŠããã®æªæ§ç©è³ªã§ãããªãŠããå åïŒèªå·±æ
äœïŒãå ç«è€åäœã®åžçé€å»èœã枬å®ããããªãŠ
ããå åã®æž¬å®ã¯ãã©ããã¯ã¹åéãã¹ããå身
æäœè¡çåéãã¹ãã«ãŠè¡ã€ãã ã©ããã¯ã¹åéãã¹ãã¯ãããªã¹ãã¬ã³ã©ãã
ã¯ã¹ç²åã«ããâγâã°ãããªã³ãåžçãããã
ã®ã«ããªãŠããå åãå«ãæ£è è¡æŒ¿ãäœçšããã
ãšãã©ããã¯ã¹ç²åãåéããæ§è³ªãæ€åºæ³ãšã
ãŠæž¬å®ãããã®ã§ãããéåžžè¡æŒ¿ã®åžéç³»åãäœ
æããŠãã©ããã¯ã¹ç²åãåéããªããªãè¡æŒ¿åž
éåçã§ãªãŠããå åæ¿åºŠãè©äŸ¡ãããã®ã§ã
ãããªãŠããå åãé«æ¿åºŠã«å«ãè¡æŒ¿ã¯ãé°æ§ã«
ãªãåžéåçãé«ããªããäœæ¿åºŠã®è¡æŒ¿ã¯éã«äœ
ããªãã å身æäœè¡çåéãã¹ãã¯ããããžèµ€è¡çã«ãŠ
ãµã®âγâã°ãããªã³ãåžçããããã®ã§ããã
ä»ã¯ã©ããã¯ã¹åéãã¹ããšåãã§ãããäžè¬
ã«ãå身æäœè¡çåéãã¹ãã®æ³ãã©ããã¯ã¹å
éãã¹ããããªãŠããå åç¹ç°æ§ãé«ããšãããŠ
ããã ã°ãªã·ã³é£å¡©ç·©è¡æ¶²ã§åžéç³»åãäœæããŠãã©
ããã¯ã¹åéãã¹ãã«ãŠãªãŠããå åã®é°æ§ã«ãª
ãåžéåçãæ±ãããã©ããã¯ã¹åéãã¹ãã¯ã
æ¥æ¬åçµä¹Ÿç¥ç 究æã®ããããçšããŠè¡ã€ããå
æ§ã«å身æäœè¡çåéãã¹ããRAHAãã¹ãã
å¯å£«èåšè£œè¬(æ ª)補ãã«ãŠè©äŸ¡ããã ãŸããå ç«è€åäœã®æž¬å®ã¯ãããªãšãã¬ã³ã°ãª
ã³ãŒã«ãè£äœæº¶è¡æ³ã«ãã€ãããã®æ¹æ³ã¯ããªãš
ãã¬ã³ã°ãªã³ãŒã«ã§æ²éååããå ç«è€åäœãã
ããå¥åº·äººè¡æž äžã®è£äœãšåå¿ãããæ®äœã®è£äœ
éãæäœãçµåããèµ€è¡çã®æº¶è¡éã§æž¬å®ããã
ãšã«ãããå ç«è€åäœéãè©äŸ¡ãããã®ã§ããã
ãã®æ¹æ³ã®æäœæ¹æ³ãæ¡ä»¶ã¯ä»¥äžã®éãã§ããã (1) æ€äœ0.3mlãåé¢ç®¡ã«æ³šãã0.2M EDTA50ÎŒ
ãå ãæ¹æãããã»ãé žãããã¢âïŒPBSïŒ
50ÎŒãå ãæ¹æããã12.5ïŒ PEGïŒããªãšãã¬ã³
ã°ãªã³ãŒã«ïŒïŒMw7500ïŒã0.1mlå ãæ¹æãã
ïŒâ90miné眮ããã (2) ïŒâã1700ïœ10miné å¿ããåŸãããæ²æŸ±ã
2.5ïŒ PEG1.0mlã§æŽãã1700ïœ15miné å¿ãã
äžæž ãæåºããã (3) 37âã®GVB++ïŒïŒäŸ¡éœã€ãªã³ãå«ããŒã©ãã³
ããããŒã«ãããã¢ãŒïŒ30ÎŒãå ããæ²æŸ±ã
溶解ãããè£äœæºãšããŠããŒã«å¥åº·äººè¡æž 10ÎŒ
å ããã37âã30minãå ç«è€åäœãšè£äœãš
ãåå¿ãããã (4) 1.5Ã108ïŒmlEAïŒæäœæäœèµ€è¡çïŒ1.0mlãå
ãã37â60min浞ãšããããŠãæ®åè£äœã«ãã
溶è¡åå¿ãä¿é²ãããã (5) åå¿åŸãïŒâã®çé£æ°Ž6.5mlãå ããŠé å¿ãã
äžæž ã®åžå 床ïŒOD414ïŒã枬å®ããã (6) å¯Ÿç §ïŒå¥åº·äººè¡æž ïŒã«å¯Ÿãã溶è¡ã®é»æ¢çã
ç®åºããåäœãPEGâc.c.ïŒ ãšããã ãé»æ¢çïŒå¯Ÿç §âæ€äœåžå 床ïŒå¯Ÿç §åžå 床Ã100ã ãé€å»çïŒæªåŠçâåŠçè¡æŒ¿é»æ¢çïŒæªåŠçè¡æŒ¿é»æ¢
çÃ100ã ãªããEAã¯æ¥æ¬åçµä¹Ÿç¥ç 究æ補ã®è£äœäŸ¡æž¬
å®çšæäœèµ€è¡çïŒKWïŒãçšããããŸããã°ãã
ãªã³ã¯åèäŸïŒã§çšããæ¹æ³ã«ãã€ãŠæž¬å®ããã æªæŽ»æ§åã»ãã¢ããŒãºãåèäŸïŒãšåæ§ã«ã³ã³
ãããŒã«ãšããŠçšããçµæã¯ã³ã³ãããŒã«ãïŒãš
ããå Žåã®é€å»çã§è¡šâïŒã«ç€ºããã è¡šâïŒãããçæ°Žæ§ã¢ããé žããã³ãã®èªå°äœ
ã§ããããªãããã¢ã³ãããªãããã¢ã³ã¡ãã«ãš
ã¹ãã«ãããªãã¿ãã³ãïœâããšãã«ã¢ã©ãã³ã¡
ãã«ãšã¹ãã«ãã°ãããªã³ããªãŠããå åãå ç«
è€åäœãç¹ç°çãã€é«çã«åžçé€å»ããããšãæ
ããã§ããã
ãã¢ã³ã¡ãã«ãšã¹ãã«ãããªãã¿ãã³ãïœâããš
ãã«ã¢ã©ãã³ã¡ãã«ãšã¹ãã«ããããè¡æŒ¿ã®ä»£ã
ãã«ããæ ¢æ§é¢ç¯ãªãŠããæ£è è¡æŒ¿ãçšãã以å€
ã¯ãåèäŸïŒãšåæ§ãå®éšãè¡ã€ããæ ¢æ§é¢ç¯ãª
ãŠããã®æªæ§ç©è³ªã§ãããªãŠããå åïŒèªå·±æ
äœïŒãå ç«è€åäœã®åžçé€å»èœã枬å®ããããªãŠ
ããå åã®æž¬å®ã¯ãã©ããã¯ã¹åéãã¹ããå身
æäœè¡çåéãã¹ãã«ãŠè¡ã€ãã ã©ããã¯ã¹åéãã¹ãã¯ãããªã¹ãã¬ã³ã©ãã
ã¯ã¹ç²åã«ããâγâã°ãããªã³ãåžçãããã
ã®ã«ããªãŠããå åãå«ãæ£è è¡æŒ¿ãäœçšããã
ãšãã©ããã¯ã¹ç²åãåéããæ§è³ªãæ€åºæ³ãšã
ãŠæž¬å®ãããã®ã§ãããéåžžè¡æŒ¿ã®åžéç³»åãäœ
æããŠãã©ããã¯ã¹ç²åãåéããªããªãè¡æŒ¿åž
éåçã§ãªãŠããå åæ¿åºŠãè©äŸ¡ãããã®ã§ã
ãããªãŠããå åãé«æ¿åºŠã«å«ãè¡æŒ¿ã¯ãé°æ§ã«
ãªãåžéåçãé«ããªããäœæ¿åºŠã®è¡æŒ¿ã¯éã«äœ
ããªãã å身æäœè¡çåéãã¹ãã¯ããããžèµ€è¡çã«ãŠ
ãµã®âγâã°ãããªã³ãåžçããããã®ã§ããã
ä»ã¯ã©ããã¯ã¹åéãã¹ããšåãã§ãããäžè¬
ã«ãå身æäœè¡çåéãã¹ãã®æ³ãã©ããã¯ã¹å
éãã¹ããããªãŠããå åç¹ç°æ§ãé«ããšãããŠ
ããã ã°ãªã·ã³é£å¡©ç·©è¡æ¶²ã§åžéç³»åãäœæããŠãã©
ããã¯ã¹åéãã¹ãã«ãŠãªãŠããå åã®é°æ§ã«ãª
ãåžéåçãæ±ãããã©ããã¯ã¹åéãã¹ãã¯ã
æ¥æ¬åçµä¹Ÿç¥ç 究æã®ããããçšããŠè¡ã€ããå
æ§ã«å身æäœè¡çåéãã¹ããRAHAãã¹ãã
å¯å£«èåšè£œè¬(æ ª)補ãã«ãŠè©äŸ¡ããã ãŸããå ç«è€åäœã®æž¬å®ã¯ãããªãšãã¬ã³ã°ãª
ã³ãŒã«ãè£äœæº¶è¡æ³ã«ãã€ãããã®æ¹æ³ã¯ããªãš
ãã¬ã³ã°ãªã³ãŒã«ã§æ²éååããå ç«è€åäœãã
ããå¥åº·äººè¡æž äžã®è£äœãšåå¿ãããæ®äœã®è£äœ
éãæäœãçµåããèµ€è¡çã®æº¶è¡éã§æž¬å®ããã
ãšã«ãããå ç«è€åäœéãè©äŸ¡ãããã®ã§ããã
ãã®æ¹æ³ã®æäœæ¹æ³ãæ¡ä»¶ã¯ä»¥äžã®éãã§ããã (1) æ€äœ0.3mlãåé¢ç®¡ã«æ³šãã0.2M EDTA50ÎŒ
ãå ãæ¹æãããã»ãé žãããã¢âïŒPBSïŒ
50ÎŒãå ãæ¹æããã12.5ïŒ PEGïŒããªãšãã¬ã³
ã°ãªã³ãŒã«ïŒïŒMw7500ïŒã0.1mlå ãæ¹æãã
ïŒâ90miné眮ããã (2) ïŒâã1700ïœ10miné å¿ããåŸãããæ²æŸ±ã
2.5ïŒ PEG1.0mlã§æŽãã1700ïœ15miné å¿ãã
äžæž ãæåºããã (3) 37âã®GVB++ïŒïŒäŸ¡éœã€ãªã³ãå«ããŒã©ãã³
ããããŒã«ãããã¢ãŒïŒ30ÎŒãå ããæ²æŸ±ã
溶解ãããè£äœæºãšããŠããŒã«å¥åº·äººè¡æž 10ÎŒ
å ããã37âã30minãå ç«è€åäœãšè£äœãš
ãåå¿ãããã (4) 1.5Ã108ïŒmlEAïŒæäœæäœèµ€è¡çïŒ1.0mlãå
ãã37â60min浞ãšããããŠãæ®åè£äœã«ãã
溶è¡åå¿ãä¿é²ãããã (5) åå¿åŸãïŒâã®çé£æ°Ž6.5mlãå ããŠé å¿ãã
äžæž ã®åžå 床ïŒOD414ïŒã枬å®ããã (6) å¯Ÿç §ïŒå¥åº·äººè¡æž ïŒã«å¯Ÿãã溶è¡ã®é»æ¢çã
ç®åºããåäœãPEGâc.c.ïŒ ãšããã ãé»æ¢çïŒå¯Ÿç §âæ€äœåžå 床ïŒå¯Ÿç §åžå 床Ã100ã ãé€å»çïŒæªåŠçâåŠçè¡æŒ¿é»æ¢çïŒæªåŠçè¡æŒ¿é»æ¢
çÃ100ã ãªããEAã¯æ¥æ¬åçµä¹Ÿç¥ç 究æ補ã®è£äœäŸ¡æž¬
å®çšæäœèµ€è¡çïŒKWïŒãçšããããŸããã°ãã
ãªã³ã¯åèäŸïŒã§çšããæ¹æ³ã«ãã€ãŠæž¬å®ããã æªæŽ»æ§åã»ãã¢ããŒãºãåèäŸïŒãšåæ§ã«ã³ã³
ãããŒã«ãšããŠçšããçµæã¯ã³ã³ãããŒã«ãïŒãš
ããå Žåã®é€å»çã§è¡šâïŒã«ç€ºããã è¡šâïŒãããçæ°Žæ§ã¢ããé žããã³ãã®èªå°äœ
ã§ããããªãããã¢ã³ãããªãããã¢ã³ã¡ãã«ãš
ã¹ãã«ãããªãã¿ãã³ãïœâããšãã«ã¢ã©ãã³ã¡
ãã«ãšã¹ãã«ãã°ãããªã³ããªãŠããå åãå ç«
è€åäœãç¹ç°çãã€é«çã«åžçé€å»ããããšãæ
ããã§ããã
ãè¡šã
äžè¡šãããçæ°Žæ§ã¢ããé
žããã³ãã®èªå°äœ
ããã°ãããªã³ãç¹ç°çãã€é«çã«åžçããã
ãšãããã«ãããé«çãã€ç¹ç°çã«ãªãŠããå
åãå ç«è€åäœãåžçããããšã¯æããã§ããã æ¯èŒäŸ ïŒ ãããã€ã³ïŒ¡âã»ãã¢ããŒãºCLâ4BïŒã¹ãŠãš
ãŒãã³ããã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããŠãå®æœäŸïŒ
ãšåæ§ã®å®éšãè¡ã€ããã°ãããªã³ã®å®éã¯ãé«
é液äœã¯ãããã°ã©ãïŒã«ã©ã 3000SW2æ¬æ±æŽ
æ¹é補ïŒãçšããŠè¡ã€ãããŸããä¿åå®å®æ§ãè©
䟡ããããããããã€ã³ïŒ¡âã»ãã¢ããŒãºCLâ
4Bãççé£å¡©æ¶²ã«æžæ¿ãã100âã60ååŠçãã
ãã®ãçšããŠãåæ§ã®å®éšãè¡ã€ããã³ã³ãããŒ
ã«ãã»ãã¢ããŒãºCLâ4Bãšãããçµæãè¡šâïŒ
ã«ç€ºããã
ããã°ãããªã³ãç¹ç°çãã€é«çã«åžçããã
ãšãããã«ãããé«çãã€ç¹ç°çã«ãªãŠããå
åãå ç«è€åäœãåžçããããšã¯æããã§ããã æ¯èŒäŸ ïŒ ãããã€ã³ïŒ¡âã»ãã¢ããŒãºCLâ4BïŒã¹ãŠãš
ãŒãã³ããã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããŠãå®æœäŸïŒ
ãšåæ§ã®å®éšãè¡ã€ããã°ãããªã³ã®å®éã¯ãé«
é液äœã¯ãããã°ã©ãïŒã«ã©ã 3000SW2æ¬æ±æŽ
æ¹é補ïŒãçšããŠè¡ã€ãããŸããä¿åå®å®æ§ãè©
䟡ããããããããã€ã³ïŒ¡âã»ãã¢ããŒãºCLâ
4Bãççé£å¡©æ¶²ã«æžæ¿ãã100âã60ååŠçãã
ãã®ãçšããŠãåæ§ã®å®éšãè¡ã€ããã³ã³ãããŒ
ã«ãã»ãã¢ããŒãºCLâ4Bãšãããçµæãè¡šâïŒ
ã«ç€ºããã
ãè¡šã
äžè¡šããæãããªããã«ããããã€ã³ïŒ¡âã»ã
ã¢ããŒãºã¯ãçæ°Žæ§ã¢ããé žããã³ãã®èªå°äœã«
æ¯ããé€å»çãäœããç±åŠçããæãç¹ç°æ§ãäœ
äžããŠå¥œãŸãããã®ã§ã¯ãªãã å®æœäŸ ïŒ ãªãŠããæ£è è¡æŒ¿ã®ä»£ããã«ãå šèº«è£œãšãªãã
ããŒãã¹æ£è è¡æŒ¿ãçšãã以å€ã¯ãå®æœäŸïŒãšå
æ§ã«å®æœãããçµæãè¡šâïŒã«ç€ºããã
ã¢ããŒãºã¯ãçæ°Žæ§ã¢ããé žããã³ãã®èªå°äœã«
æ¯ããé€å»çãäœããç±åŠçããæãç¹ç°æ§ãäœ
äžããŠå¥œãŸãããã®ã§ã¯ãªãã å®æœäŸ ïŒ ãªãŠããæ£è è¡æŒ¿ã®ä»£ããã«ãå šèº«è£œãšãªãã
ããŒãã¹æ£è è¡æŒ¿ãçšãã以å€ã¯ãå®æœäŸïŒãšå
æ§ã«å®æœãããçµæãè¡šâïŒã«ç€ºããã
ãè¡šã
äžè¡šãããçæ°Žæ§ã¢ããé
žããã³ãã®èªå°äœ
ããå šèº«æ§ãšãªããããŒãã¹æ£è è¡æŒ¿äžã®å ç«è€
åäœããã³æDNAæäœããããé«çãã€ç¹ç°ç
ã«åžçããããšã¯æããã§ããã ãªããæDNAæäœã®æž¬å®ã¯ããã«ããªã³åºå®
ãã¯ããªè¡çã«DNAãæäœãããã®ã«ãæDNA
æäœãå«ãæ£è è¡æŒ¿ãäœçšããããšããã¯ããªè¡
çãåéããæ§è³ªãæ€åºæ³ãšããŠæž¬å®ãããã®ã§
ãããä»ã¯ã©ããã¯ã¹åéãã¹ããšåæ§ã«ããŠæ
DNAæäœéã枬å®ããã枬å®ã¯DNAãã¹ããã
ãïŒå¯å£«èåšè£œè¬(æ ª)ïŒãçšããŠè¡ã€ãã å®æœäŸ ïŒ ïœãïœããªãããã¢ã³ãïœãïœããšãã«ã¢ã©ã
ã³ãšïœãïœãªãžã³ã®ïŒïŒïŒãªãªãŽãããããâ
ã«ã«ãã³é žç¡æ°Žç©æ³ã«ãŠãïœâããã·ã«ã¢ãã³ã
éå§å€ã«çšããŠåæããããªãžã³ã®Îµâã¢ããåº
ã¯äºãã«ã«ããã³ãŸãã·åºã§ä¿è·ãããªãªãŽãã
ããåæåŸåžžæ³ã«ããé€å»ãããçæãããªãªãŽ
ããããã®éå床ïŒæ°å¹³åïŒã¯æ«ç«¯ã¢ããåºãå
èäŸïŒãšåæ§ã«èå åæã«ããæ±ãããåãªãªãŽ
ããŒã掻æ§åCHâã»ãã¢ããŒãº4Bã«åžžæ³ã«ãã
çµåããã°ãªã·ã³ãããã¢ãŒã§ããããã³ã°åŸæŽ
æµããå®æœäŸïŒãšåæ§ã®å®éšãè¡ã€ãããŸããã³
ã³ãããŒã«ããšã¿ããŒã«ã¢ãã³ã§ãããã¯ãã
CHâSepharose4Bãšãããçµæãè¡šâïŒã«ç€ºã
ãã
ããå šèº«æ§ãšãªããããŒãã¹æ£è è¡æŒ¿äžã®å ç«è€
åäœããã³æDNAæäœããããé«çãã€ç¹ç°ç
ã«åžçããããšã¯æããã§ããã ãªããæDNAæäœã®æž¬å®ã¯ããã«ããªã³åºå®
ãã¯ããªè¡çã«DNAãæäœãããã®ã«ãæDNA
æäœãå«ãæ£è è¡æŒ¿ãäœçšããããšããã¯ããªè¡
çãåéããæ§è³ªãæ€åºæ³ãšããŠæž¬å®ãããã®ã§
ãããä»ã¯ã©ããã¯ã¹åéãã¹ããšåæ§ã«ããŠæ
DNAæäœéã枬å®ããã枬å®ã¯DNAãã¹ããã
ãïŒå¯å£«èåšè£œè¬(æ ª)ïŒãçšããŠè¡ã€ãã å®æœäŸ ïŒ ïœãïœããªãããã¢ã³ãïœãïœããšãã«ã¢ã©ã
ã³ãšïœãïœãªãžã³ã®ïŒïŒïŒãªãªãŽãããããâ
ã«ã«ãã³é žç¡æ°Žç©æ³ã«ãŠãïœâããã·ã«ã¢ãã³ã
éå§å€ã«çšããŠåæããããªãžã³ã®Îµâã¢ããåº
ã¯äºãã«ã«ããã³ãŸãã·åºã§ä¿è·ãããªãªãŽãã
ããåæåŸåžžæ³ã«ããé€å»ãããçæãããªãªãŽ
ããããã®éå床ïŒæ°å¹³åïŒã¯æ«ç«¯ã¢ããåºãå
èäŸïŒãšåæ§ã«èå åæã«ããæ±ãããåãªãªãŽ
ããŒã掻æ§åCHâã»ãã¢ããŒãº4Bã«åžžæ³ã«ãã
çµåããã°ãªã·ã³ãããã¢ãŒã§ããããã³ã°åŸæŽ
æµããå®æœäŸïŒãšåæ§ã®å®éšãè¡ã€ãããŸããã³
ã³ãããŒã«ããšã¿ããŒã«ã¢ãã³ã§ãããã¯ãã
CHâSepharose4Bãšãããçµæãè¡šâïŒã«ç€ºã
ãã
ãè¡šã
äžè¡šãããçæ°Žæ§ã¢ããé
žãå«ããªãªãŽããã
ãããã°ãããªã³ãããã«ã¯ãªãŠããå åãå ç«
è€åäœãç¹ç°çã«åžçé€å»ããããšã¯æããã§ã
ãã åèäŸ ïŒ ããã«ååç©ç³»å€åæ§éåäœãšããŠããããã
ã·ã«ãšãã«ã¡ã¿ã¢ã¯ãªã¬ãŒãâãšãã¬ã³ã°ãªã³ãŒ
ã«ãžã¡ã¿ã¢ã¯ãªã¬ãŒãâã°ã¬ã·ãžã«ã¡ã¿ã¢ã¯ãªã¬
ãŒããããªãäžå å ±éåäœã®å¹³åç²åŸãå¹³åååŸ
ãçš®ã ç°ãªãéåäœãçšããŠå®éšãè¡ã€ããéå
äœäžã®ãšããã·å¯åºŠã¯1molïŒ ã§ãããçæ°Žæ§ã¢
ããé žã®èªå°äœãšããŠãïœâããªãããã¢ã³ã¡ã
ã«ãšã¹ãã«ãçšããåžžæ³ã«ããåºå®ãããæªåå¿
ãšããã·ãã¯ãšã¿ããŒã«ã¢ãã³ãçšããŠãããã¯
ãããä¿æéã¯4.3mgïŒmlã¬ãžã³ã§ãã€ããã³ã³
ãããŒã«ãšããŠãšããã·ããå šéãšã¿ããŒã«ã¢ã
ã³ã§ãããã¯ãããã®ãçšãããåèäŸïŒãšåæ§
ã«ååã«æŽæµãããã®ãå®éšã«äŸããã該åžçæ
ïŒmlã第ïŒå³ã®åŠã容åšå ã«åçŽããã°ãããªã³
ã®é€å»è£ 眮ãäœæããã 第ïŒå³ã«ç€ºãå®éšç³»ãçšããŠã°ãããªã³ã®åžç
å®éšãè¡ã€ãã ããªãã¡ã容åšïŒïŒãšããå¥åº·äººè¡æ¶²ïŒïŒã25
mlå ¥ãããã³ãïŒïŒã«ããæ¯åïŒmlã®æµéã§æ±²ã¿
åºããã€ã ãã°ãããªã³ã®é€å»è£ 眮ïŒã«éããã
ãªãããã€ã³ããŒïŒïŒããã³ãµã³ããªã³ã°å£ïŒïŒ
ãçµãŠã容åšïŒïŒã«è¿éãããããã«ããŠãŒãïŒ
ïŒãé èšããããªããè¡æ¶²äžã«ã¯ãããªã³ïŒïŒïŒ
ãæ·»å ããã äžèšè£ 眮ã«ãããè¡æ¶²ããïŒæé埪ç°ããã
åŸãè¡æ¶²ããµã³ããªã³ã°ããè¡æŒ¿äžã®ã®ã°ãããª
ã³éã枬å®ãããçµæãè¡šâïŒã«ç€ºããã ãããã®å Žåãã埪ç°ã®ååŸã§çœè¡çãè¡å°æ¿
ã®æžå°ã¯å°ãªãã€ãã
ãããã°ãããªã³ãããã«ã¯ãªãŠããå åãå ç«
è€åäœãç¹ç°çã«åžçé€å»ããããšã¯æããã§ã
ãã åèäŸ ïŒ ããã«ååç©ç³»å€åæ§éåäœãšããŠããããã
ã·ã«ãšãã«ã¡ã¿ã¢ã¯ãªã¬ãŒãâãšãã¬ã³ã°ãªã³ãŒ
ã«ãžã¡ã¿ã¢ã¯ãªã¬ãŒãâã°ã¬ã·ãžã«ã¡ã¿ã¢ã¯ãªã¬
ãŒããããªãäžå å ±éåäœã®å¹³åç²åŸãå¹³åååŸ
ãçš®ã ç°ãªãéåäœãçšããŠå®éšãè¡ã€ããéå
äœäžã®ãšããã·å¯åºŠã¯1molïŒ ã§ãããçæ°Žæ§ã¢
ããé žã®èªå°äœãšããŠãïœâããªãããã¢ã³ã¡ã
ã«ãšã¹ãã«ãçšããåžžæ³ã«ããåºå®ãããæªåå¿
ãšããã·ãã¯ãšã¿ããŒã«ã¢ãã³ãçšããŠãããã¯
ãããä¿æéã¯4.3mgïŒmlã¬ãžã³ã§ãã€ããã³ã³
ãããŒã«ãšããŠãšããã·ããå šéãšã¿ããŒã«ã¢ã
ã³ã§ãããã¯ãããã®ãçšãããåèäŸïŒãšåæ§
ã«ååã«æŽæµãããã®ãå®éšã«äŸããã該åžçæ
ïŒmlã第ïŒå³ã®åŠã容åšå ã«åçŽããã°ãããªã³
ã®é€å»è£ 眮ãäœæããã 第ïŒå³ã«ç€ºãå®éšç³»ãçšããŠã°ãããªã³ã®åžç
å®éšãè¡ã€ãã ããªãã¡ã容åšïŒïŒãšããå¥åº·äººè¡æ¶²ïŒïŒã25
mlå ¥ãããã³ãïŒïŒã«ããæ¯åïŒmlã®æµéã§æ±²ã¿
åºããã€ã ãã°ãããªã³ã®é€å»è£ 眮ïŒã«éããã
ãªãããã€ã³ããŒïŒïŒããã³ãµã³ããªã³ã°å£ïŒïŒ
ãçµãŠã容åšïŒïŒã«è¿éãããããã«ããŠãŒãïŒ
ïŒãé èšããããªããè¡æ¶²äžã«ã¯ãããªã³ïŒïŒïŒ
ãæ·»å ããã äžèšè£ 眮ã«ãããè¡æ¶²ããïŒæé埪ç°ããã
åŸãè¡æ¶²ããµã³ããªã³ã°ããè¡æŒ¿äžã®ã®ã°ãããª
ã³éã枬å®ãããçµæãè¡šâïŒã«ç€ºããã ãããã®å Žåãã埪ç°ã®ååŸã§çœè¡çãè¡å°æ¿
ã®æžå°ã¯å°ãªãã€ãã
ãè¡šã
åèäŸ ïŒ
0.5ãããŒã«ã®ãã³ãã«ã°é·ç¹ç¶ïŒæåæå·¥æ¥
補ïŒãçšããŠãåžžæ³ã«ããCNBr掻æ§åããïœâ
ããªãããã¢ã³ã¡ãã«ãšã¹ãã«ãåºå®ããããã
ããã³ã°ãæŽæµã¯åèäŸïŒã«ãã€ããä¿æéã¯
9.8mgïŒïœãã³ãã«ã°ã§ãã€ãã該åžçæãçšã
ãŠãå®æœäŸïŒãšåæ§ã®å®éšãè¡ã€ãã第ïŒå³ã®å®¹
åšã«ã¯ã該åžçæãïŒïœïŒãã³ãã«ã°ä¹Ÿç¥ééïŒ
åçŽãããïŒå å¡«å¯åºŠ0.2ïœïŒmlïŒãå¥ã«ã³ã³ãã
ãŒã«ãšããŠæªåŠçãã³ãã«ã°ãçšããŠæ¯èŒããã
çµæãè¡šâïŒã«ç€ºããããŸãã埪ç°ã®ååŸã§çœè¡
çãè¡å°æ¿ã®æžå°ã¯æ¯èŒçå°ãªãã€ãã
補ïŒãçšããŠãåžžæ³ã«ããCNBr掻æ§åããïœâ
ããªãããã¢ã³ã¡ãã«ãšã¹ãã«ãåºå®ããããã
ããã³ã°ãæŽæµã¯åèäŸïŒã«ãã€ããä¿æéã¯
9.8mgïŒïœãã³ãã«ã°ã§ãã€ãã該åžçæãçšã
ãŠãå®æœäŸïŒãšåæ§ã®å®éšãè¡ã€ãã第ïŒå³ã®å®¹
åšã«ã¯ã該åžçæãïŒïœïŒãã³ãã«ã°ä¹Ÿç¥ééïŒ
åçŽãããïŒå å¡«å¯åºŠ0.2ïœïŒmlïŒãå¥ã«ã³ã³ãã
ãŒã«ãšããŠæªåŠçãã³ãã«ã°ãçšããŠæ¯èŒããã
çµæãè¡šâïŒã«ç€ºããããŸãã埪ç°ã®ååŸã§çœè¡
çãè¡å°æ¿ã®æžå°ã¯æ¯èŒçå°ãªãã€ãã
ãè¡šã
å®æœäŸ ïŒ
CNBr掻æ§åã»ãã¢ããŒãº4BïŒã¹ãŠãšãŒãã³ã
ãã¢ã«ãã·ã¢ç€Ÿè£œïŒã«ãéåžžã®æ¹æ³ã«ãããçæ°Ž
æ§ã¢ããé žã§ããïœâããªãããã¢ã³ãïœâããš
ãã«ã¢ã©ãã³ãåºå®ãåžçæãšãããããããã³
ã°ãæŽæµã¯åèäŸïŒãšåæ§ã«è¡ããä¿æéã®æž¬å®
ãåæ§ã«è¡ã€ããä¿æéã¯ãïœâããªãããã¢ã³
ã2.3mgïŒmlã»ãã¢ããŒãºïŒæ¹¿æœ€ã«ã©ã 容éïŒãïœ
âããšãã«ã¢ã©ãã³ãã2.0mgïŒmlã»ãã¢ããŒãº
ã§ãã€ãã åžçå®éšã¯ãéççç¡åçæ£è è¡æŒ¿ïŒå®¹ã«å¯Ÿã
æ°ŽåãããåžçæïŒå®¹ãæ··åãã37âãïŒæéã
æ¯ãšãããªãããã€ã³ããŠããŒããããåžçåŸã®
è¡æŒ¿äžãåã¢ã»ãã«ã³ãªã³ã¬ã»ãã¿ãŒæäœïŒèªå·±
æäœïŒããªã³ãã¹ããã ïŒLindstromïŒã®ïŒæäœ
æ³ã«ãŠæž¬å®ããããŸããæªæŽ»æ§åã»ãã¢ããŒãº
4BãçšããŠåžçå®éšãè¡ããã³ã³ãããŒã«ãšã
ãã çµæã¯ãã³ã³ãããŒã«ãïŒãšããå Žåã®é€å»ç
ã§è¡šâïŒã«ç€ºãããè¡šâïŒãããã»ãã¢ããŒãº
4Bã«ïœâããªãããã¢ã³ãïœâããšãã«ã¢ã©ã
ã³ãåºå®åããåžçæããéççç¡åçã®èªå·±æ
äœã§ããæã¢ã»ãã«ã³ãªã³ã¬ã»ãã¿ãŒæäœãéžæ
çããã€é«çã«åžçããããšãæããã§ããã
ãã¢ã«ãã·ã¢ç€Ÿè£œïŒã«ãéåžžã®æ¹æ³ã«ãããçæ°Ž
æ§ã¢ããé žã§ããïœâããªãããã¢ã³ãïœâããš
ãã«ã¢ã©ãã³ãåºå®ãåžçæãšãããããããã³
ã°ãæŽæµã¯åèäŸïŒãšåæ§ã«è¡ããä¿æéã®æž¬å®
ãåæ§ã«è¡ã€ããä¿æéã¯ãïœâããªãããã¢ã³
ã2.3mgïŒmlã»ãã¢ããŒãºïŒæ¹¿æœ€ã«ã©ã 容éïŒãïœ
âããšãã«ã¢ã©ãã³ãã2.0mgïŒmlã»ãã¢ããŒãº
ã§ãã€ãã åžçå®éšã¯ãéççç¡åçæ£è è¡æŒ¿ïŒå®¹ã«å¯Ÿã
æ°ŽåãããåžçæïŒå®¹ãæ··åãã37âãïŒæéã
æ¯ãšãããªãããã€ã³ããŠããŒããããåžçåŸã®
è¡æŒ¿äžãåã¢ã»ãã«ã³ãªã³ã¬ã»ãã¿ãŒæäœïŒèªå·±
æäœïŒããªã³ãã¹ããã ïŒLindstromïŒã®ïŒæäœ
æ³ã«ãŠæž¬å®ããããŸããæªæŽ»æ§åã»ãã¢ããŒãº
4BãçšããŠåžçå®éšãè¡ããã³ã³ãããŒã«ãšã
ãã çµæã¯ãã³ã³ãããŒã«ãïŒãšããå Žåã®é€å»ç
ã§è¡šâïŒã«ç€ºãããè¡šâïŒãããã»ãã¢ããŒãº
4Bã«ïœâããªãããã¢ã³ãïœâããšãã«ã¢ã©ã
ã³ãåºå®åããåžçæããéççç¡åçã®èªå·±æ
äœã§ããæã¢ã»ãã«ã³ãªã³ã¬ã»ãã¿ãŒæäœãéžæ
çããã€é«çã«åžçããããšãæããã§ããã
ãè¡šã
å®æœäŸïŒãïŒããã³æ¯èŒäŸïŒãïŒ
çæ°Žæ§ååç©ãšããŠããã·ã³ïŒå®æœäŸïŒïŒãã
ãªãããã¢ã³ïŒå®æœäŸïŒïŒãããšãã«ã¢ã©ãã³
ïŒå®æœäŸïŒïŒããã¹ããžã³ïŒå®æœäŸïŒïŒãããªã³
ïŒå®æœäŸïŒïŒãçšãããŸãã芪氎æ§ååç©ãšããŠ
DLâãã¬ãªãã³ïŒæ¯èŒäŸïŒïŒãããããã·ãããª
ã³ïŒæ¯èŒäŸïŒïŒããããªã³ïŒæ¯èŒäŸïŒïŒãçšããŠã
å®æœäŸïŒãšåæ§ãå®éšãè¡ã€ãã çµæãè¡šâ10ã«ç€ºããããã®çµæããã25âã«
ããã察ççé£å¡©æ°Žæº¶è§£åºŠã100ããªã¢ã«ïŒdl以
äžã®çæ°Žæ§ã¢ããé žãçµåããåžçæããã°ãã
ãªã³ããªãŠããå åãå ç«è€åäœãéžæçãã
ã€ãé«çã«åžçé€å»ããããšããããã
ãªãããã¢ã³ïŒå®æœäŸïŒïŒãããšãã«ã¢ã©ãã³
ïŒå®æœäŸïŒïŒããã¹ããžã³ïŒå®æœäŸïŒïŒãããªã³
ïŒå®æœäŸïŒïŒãçšãããŸãã芪氎æ§ååç©ãšããŠ
DLâãã¬ãªãã³ïŒæ¯èŒäŸïŒïŒãããããã·ãããª
ã³ïŒæ¯èŒäŸïŒïŒããããªã³ïŒæ¯èŒäŸïŒïŒãçšããŠã
å®æœäŸïŒãšåæ§ãå®éšãè¡ã€ãã çµæãè¡šâ10ã«ç€ºããããã®çµæããã25âã«
ããã察ççé£å¡©æ°Žæº¶è§£åºŠã100ããªã¢ã«ïŒdl以
äžã®çæ°Žæ§ã¢ããé žãçµåããåžçæããã°ãã
ãªã³ããªãŠããå åãå ç«è€åäœãéžæçãã
ã€ãé«çã«åžçé€å»ããããšããããã
第ïŒå³ã¯æ¬çºæã®ã°ãããªã³ç³»ååç©ã®åžçè£
眮ã®ïŒäŸã瀺ãæé¢å³ã第ïŒå³ã¯å®æœäŸã«ããã
ã¢ãã«å®éšèª¬æå³ã§ããã ïŒâŠâŠèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®é€
å»è£ 眮ãïŒâŠâŠåçãïŒïŒïŒâ²âŠâŠãã€ã«ã¿ãŒã
ïŒïŒïŒâ²âŠâŠãããã³ã°ãïŒâŠâŠäœæ¶²å°å ¥å£ãïŒ
âŠâŠãã€ãããïŒâŠâŠäœæ¶²å°åºå£ãïŒâŠâŠãã€ã
ããïŒâŠâŠåžçæãïŒïŒâŠâŠå®¹åšãïŒïŒâŠâŠè¡
液ãïŒïŒâŠâŠãã³ããïŒïŒâŠâŠãµã³ããªã³ã°å£ã
ïŒïŒâŠâŠããŠãŒããïŒïŒâŠâŠããªãããã€ã³ã
ãŒã
眮ã®ïŒäŸã瀺ãæé¢å³ã第ïŒå³ã¯å®æœäŸã«ããã
ã¢ãã«å®éšèª¬æå³ã§ããã ïŒâŠâŠèªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœã®é€
å»è£ 眮ãïŒâŠâŠåçãïŒïŒïŒâ²âŠâŠãã€ã«ã¿ãŒã
ïŒïŒïŒâ²âŠâŠãããã³ã°ãïŒâŠâŠäœæ¶²å°å ¥å£ãïŒ
âŠâŠãã€ãããïŒâŠâŠäœæ¶²å°åºå£ãïŒâŠâŠãã€ã
ããïŒâŠâŠåžçæãïŒïŒâŠâŠå®¹åšãïŒïŒâŠâŠè¡
液ãïŒïŒâŠâŠãã³ããïŒïŒâŠâŠãµã³ããªã³ã°å£ã
ïŒïŒâŠâŠããŠãŒããïŒïŒâŠâŠããªãããã€ã³ã
ãŒã
Claims (1)
- ïŒ 25âã«ããã察ççé£å¡©æ°Žæº¶è§£åºŠã100ïœ
molïŒdl以äžã§ããçæ°Žæ§ã¢ããé žãŸãã¯ãã®èª
å°äœããã³ïŒãŸãã¯è©²çæ°Žæ§ã¢ããé žãŸãã¯ãã®
èªå°äœãå«ããªãªãŽããŒãæ°Žäžæº¶æ§æ äœïŒmlãã
ã0.1ã30mgçµåãããŠãªãåžçæã«ãèªå·±æäœ
ããã³ïŒãŸãã¯å ç«è€åäœãå ±åããè¡æ¶²ãŸãã¯
è¡æŒ¿ãæµãããšãç¹åŸŽãšããèªå·±æäœããã³ïŒãŸ
ãã¯å ç«è€åäœãéžæçã«é€å»ãããè¡æ¶²ãŸãã¯
è¡æŒ¿ã補é ããæ¹æ³ã
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1278684A JPH03236857A (ja) | 1989-10-27 | 1989-10-27 | èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»ãããè¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1278684A JPH03236857A (ja) | 1989-10-27 | 1989-10-27 | èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»ãããè¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56007152A Division JPS57122875A (en) | 1981-01-22 | 1981-01-22 | Immunity adsorbing material and adsorbing device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03236857A JPH03236857A (ja) | 1991-10-22 |
| JPH0534024B2 true JPH0534024B2 (ja) | 1993-05-21 |
Family
ID=17600733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1278684A Granted JPH03236857A (ja) | 1989-10-27 | 1989-10-27 | èªå·±æäœããã³ïŒãŸãã¯å ç«è€åäœãéžæçã«é€å»ãããè¡æ¶²ãŸãã¯è¡æŒ¿ã補é ããæ¹æ³ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03236857A (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009297229A (ja) * | 2008-06-12 | 2009-12-24 | Nikkiso Co Ltd | è¡çé€å»ã¢ãžã¥ãŒã« |
| US8748560B2 (en) | 2008-04-18 | 2014-06-10 | Nikkiso Company, Ltd. | Adsorbent for the removal of blood cells |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53137585A (en) * | 1977-05-07 | 1978-12-01 | Toshimitsu Niwa | Artificial retina unit |
| JPS5463894A (en) * | 1977-09-19 | 1979-05-23 | Merieux Inst | New substance capable of reverstbly fixing biological gigantic molecule* and making method and applying method of said substance |
| JPS5538141A (en) * | 1978-09-09 | 1980-03-17 | Mediks Kk | Artificial net inside system device |
| JPS5586468A (en) * | 1978-12-26 | 1980-06-30 | Teijin Ltd | Adsorber for medical treatment |
| JPS57122875A (en) * | 1981-01-22 | 1982-07-30 | Asahi Chemical Ind | Immunity adsorbing material and adsorbing device |
-
1989
- 1989-10-27 JP JP1278684A patent/JPH03236857A/ja active Granted
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53137585A (en) * | 1977-05-07 | 1978-12-01 | Toshimitsu Niwa | Artificial retina unit |
| JPS5463894A (en) * | 1977-09-19 | 1979-05-23 | Merieux Inst | New substance capable of reverstbly fixing biological gigantic molecule* and making method and applying method of said substance |
| JPS5538141A (en) * | 1978-09-09 | 1980-03-17 | Mediks Kk | Artificial net inside system device |
| JPS5586468A (en) * | 1978-12-26 | 1980-06-30 | Teijin Ltd | Adsorber for medical treatment |
| JPS57122875A (en) * | 1981-01-22 | 1982-07-30 | Asahi Chemical Ind | Immunity adsorbing material and adsorbing device |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8748560B2 (en) | 2008-04-18 | 2014-06-10 | Nikkiso Company, Ltd. | Adsorbent for the removal of blood cells |
| JP2009297229A (ja) * | 2008-06-12 | 2009-12-24 | Nikkiso Co Ltd | è¡çé€å»ã¢ãžã¥ãŒã« |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03236857A (ja) | 1991-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4627915A (en) | Absorbent of autoantibody and immune complexes, adsorbing device and blood purifying apparatus comprising the same | |
| EP0056977B1 (en) | Immune adsorbent, adsorbing device and blood purifying apparatus | |
| JPS6353971B2 (ja) | ||
| JPH0144725B2 (ja) | ||
| JPH0513696B2 (ja) | ||
| JP2928589B2 (ja) | å€æ§ïœïœïœã®åžçäœããã³ãããçšããå€æ§ïœïœïœã®é€å»è£ 眮 | |
| JP2543693B2 (ja) | äœæ¯éãªãèçœè³ªã®åžçæããã³ãã®è£œé æ¹æ³ | |
| JPH0534024B2 (ja) | ||
| JPH0323182B2 (ja) | ||
| JPS59186558A (ja) | ãªãŠããå åããã³ïŒãŸãã¯ãã®å ç«è€åäœã®åžçæ | |
| JPH0424065B2 (ja) | ||
| JPS6087854A (ja) | è¡æ¶²æµååžçæ | |
| JPS5810055A (ja) | å ç«åžçåšã®è£œé æ¹æ³ | |
| JPH0215222B2 (ja) | ||
| JP2665526B2 (ja) | βïŒâãã¯ãã°ãããªã³ã®åžçæ | |
| Denizli et al. | Biologically modified PHEMA beads for hemoperfusion: preliminary studies | |
| JPS59206046A (ja) | äœæ¯éãªãèçœè³ªãåžçããææ | |
| JPS6361024B2 (ja) | ||
| JPH0113861B2 (ja) | ||
| JPH024301B2 (ja) | ||
| JPH0316639A (ja) | åžçäœããã³ãããçšããé€å»è£ 眮 | |
| JPS59189859A (ja) | èªå·±æäœãå ç«è€åäœãåžçããææ | |
| JPH05168707A (ja) | è¡æ¶²æµåçšåžçæ | |
| JPS59139937A (ja) | äœæ¯éãªãèçœåžçæ | |
| JPS6353827B2 (ja) |